FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yves Agid

Research Profile

Disorders

Anatomy

Chemicals & Drugs

Living Beings

Rats

Concepts & Ideas

Procedures

Immunohistochemistry

Co-author Network

Publications

TOP 3
Yohann Brun; Sara Fernandez-Vidal; David Grabli; Nicolas Jodoin; Carine Karachi; Luc Mallet; Yves Agid; Eric Bardinet; Jérôme Yelnik; Marie-Laure Welter
Does unilateral basal ganglia activity functionally influence the contralateral side? What we can learn from STN stimulation in patients with Parkinson's disease.
Yves Agid
Movement Disorders, the journal, and movement disorders, the field?
Paul McCrone; Christine Anne Mary Payan; Yves Agid; Gilbert Bensimon; Martin Knapp; P Nigel Leigh; Albert Ludolph
The economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United Kingdom.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yves Agid (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Yohann Brun; Sara Fernandez-Vidal; David Grabli; Nicolas Jodoin; Carine Karachi; Luc Mallet; Yves Agid; Eric Bardinet; Jérôme Yelnik; Marie-Laure Welter
Does unilateral basal ganglia activity functionally influence the contralateral side? What we can learn from STN stimulation in patients with Parkinson's disease.
Journal of neurophysiology 2012;108(6):1575-83.
2011: Yves Agid
Movement Disorders, the journal, and movement disorders, the field?
Movement disorders : official journal of the Movement Disorder Society 2011;26(6):937-8.
2011: Paul McCrone; Christine Anne Mary Payan; Yves Agid; Gilbert Bensimon; Martin Knapp; P Nigel Leigh; Albert Ludolph
The economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United Kingdom.
PloS one 2011;6(9):e24369.
2011: Christine A M Payan; Marc Verny; François Viallet; Yves Agid; Gilbert Bensimon; Frédéric Bloch; Anne-Marie Bonnet; Michel Borg; Franck Durif; Jacques Fermanian; Lucette Lacomblez; Bernhard G Landwehrmeyer; Peter N Leigh; Albert C Ludolph
Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS--Parkinson Plus Scale.
PloS one 2011;6(8):e22293.
2011: Jean-Christophe Corvol; Cécilia Bonnet; Fanny Charbonnier-Beaupel; Anne-Marie Bonnet; Marie-Hélène Fiévet; Agnès Bellanger; Emmanuel Roze; Gayané Meliksetyan; Mouna Ben Djebara; Andreas Hartmann; Lucette Lacomblez; Cédric Vrignaud; Noël Zahr; Yves Agid; Jean Costentin; Jean-Sébastien Hulot; Marie Vidailhet
The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial.
Annals of neurology 2011;69(1):111-8.
2010: Richard G Brown; Lucette Lacomblez; Bernard G Landwehrmeyer; Thomas Bak; Ingo Uttner; Bruno Dubois; Yves Agid; Albert Ludolph; Gilbert Bensimon; Christine Payan; Nigel P Leigh
Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.
Brain : a journal of neurology 2010;133(Pt 8):2382-93.
2010: Olivier Rascol; Jean-Philippe Azulay; Olivier Blin; Anne-Marie Bonnet; Christine Brefel-Courbon; Pierre Césaro; Philippe Damier; Bérengère Debilly; Frank Durif; Monique Galitzky; Jean-Marie Grouin; Sylvie Pennaforte; Gabriel Villafane; Sadek Yaici; Yves Agid
Orodispersible sublingual piribedil to abort OFF episodes: a single dose placebo-controlled, randomized, double-blind, cross-over study.
Movement disorders : official journal of the Movement Disorder Society 2010;25(3):368-76.
2010: N Chastan; G W M Westby; Sophie Tezenas du Montcel; Manh Cuong Do; Kwong Yew Chong; Yves Agid; M L Welter
Influence of sensory inputs and motor demands on the control of the centre of mass velocity during gait initiation in humans.
Neuroscience letters 2010;469(3):400-4.
2010: W M M Schüpbach; J-C Corvol; V Czernecki; M B Djebara; J-L Golmard; Yves Agid; A Hartmann
Segmental progression of early untreated Parkinson's disease: a novel approach to clinical rating.
Journal of neurology, neurosurgery, and psychiatry 2010;81(1):20-5.
2009: Sophie Lavault; Frederic Bloch; Jean-Luc Houeto; Eric Konofal; Marie-Laure Welter; Yves Agid; Isabelle Arnulf
Periodic leg movements and REM sleep without atonia in Parkinson's disease with camptocormia.
Movement disorders : official journal of the Movement Disorder Society 2009;24(16):2419-23.
2009: Maria-João Ribeiro; Stéphane Thobois; Ebba Lohmann; Sophie Tezenas du Montcel; Suzanne Lesage; Antoine Pelissolo; Bruno Dubois; Luc Mallet; Pierre Pollak; Yves Agid; Emmanuel Broussolle; Alexis Brice; Philippe Remy
A multitracer dopaminergic PET study of young-onset parkinsonian patients with and without parkin gene mutations.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(8):1244-50.
2009: Marie Vidailhet; Jerome Yelnik; Christelle Lagrange; Valérie Fraix; David Grabli; Stephane Thobois; Pierre Burbaud; Marie-Laure Welter; Jin Xie-Brustolin; Maria-Clara Coelho Braga; Claire Ardouin; Virginie Czernecki; Hélène Klinger; Stephan Chabardes; Eric Seigneuret; Patrick Mertens; Emmanuel Cuny; Soledad Navarro; Philippe Cornu; Alim-Louis Benabid; Jean-Francois Le Bas; Didier Dormont; Marc Hermier; Kathy Dujardin; Serge Blond; Pierre Krystkowiak; Alain Destée; Eric Bardinet; Yves Agid; Paul Krack; Emmanuel Broussolle; Pierre Pollak
Bilateral pallidal deep brain stimulation for the treatment of patients with dystonia-choreoathetosis cerebral palsy: a prospective pilot study.
Lancet neurology 2009;8(8):709-17.
2009: Jens Volkmann; Alberto Albanese; Jaime Kulisevsky; Aana-Lena Tornqvist; Jean-Luc Houeto; Bernard Pidoux; Anne-Marie Bonnet; Alexandre Mendes; Alim-Louis Benabid; Valérie Fraix; Nadege Van Blercom; Jing Xie; Jose A Obeso; Maria C Rodriguez-Oroz; Jurge Guridi; Alfons Schnitzler; Lars Timmermann; Alexandre A Gironell; Juan Molet; Benta Pascual-Sedano; Stig Rehncrona; Elena Moro; Anthony E Lang; Andres M Lozano; Anna Rita Bentivoglio; Massimo Scerrati; Maria Fiorella Contarino; Luigi Romito; Marc Janssens; Yves Agid
Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2009;24(8):1154-61.
2009: Ebba Lohmann; Laurence Leclere; Francesca De Anna; Suzanne Lesage; Bruno Dubois; Yves Agid; Alexandra Dürr; Alexis Brice
A clinical, neuropsychological and olfactory evaluation of a large family with LRRK2 mutations.
Parkinsonism & related disorders 2009;15(4):273-6.
2009: Eric Bardinet; Manik Bhattacharjee; Didier Dormont; Bernard Pidoux; Grégoire Malandain; Michael Schüpbach; Nicholas Ayache; Philippe Cornu; Yves Agid; Jérôme Yelnik
A three-dimensional histological atlas of the human basal ganglia. II. Atlas deformation strategy and evaluation in deep brain stimulation for Parkinson disease.
Journal of neurosurgery 2009;110(2):208-19.
2009: Pierre Payoux; Philippe Remy; Malika Miloudi; Jean-Luc Houeto; Claudio Stadler; Boulos-Paul Bejjani; Jérome Yelnik; Yves Samson; Olivier Rascol; Yves Agid; Philippe Damier
Contrasting changes in cortical activation induced by acute high-frequency stimulation within the globus pallidus in Parkinson's disease.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2009;29(2):235-43.
2009: Nathalie Chastan; Manh Cuong Do; Fabrice Bonneville; Frédéric Torny; Frédéric Bloch; G W Max Westby; Didier Dormont; Yves Agid; Marie-Laure Welter
Gait and balance disorders in Parkinson's disease: impaired active braking of the fall of centre of gravity.
Movement disorders : official journal of the Movement Disorder Society 2009;24(2):188-95.
2009: E Lohmann; S Thobois; S Lesage; E Broussolle; Sophie Tezenas du Montcel; M-J Ribeiro; P Remy; A Pelissolo; Bruno Dubois; L Mallet; Pierre Pollak; Yves Agid; Alexis Brice
A multidisciplinary study of patients with early-onset PD with and without parkin mutations.
Neurology 2009;72(2):110-6.
2009: Ammar Al-Chalabi; Alexandra Dürr; Nicholas W Wood; Michael H Parkinson; Agnes Camuzat; Jean-Sébastien Hulot; Karen E Morrison; Adrian Renton; Sigurd D Sussmuth; Bernhard G Landwehrmeyer; Albert Ludolph; Yves Agid; Alexis Brice; P Nigel Leigh; Gilbert Bensimon
Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy.
PloS one 2009;4(9):e7114.
2009: Pablo Ibáñez; Suzanne Lesage; Sabine Janin; Ebba Lohmann; Franck Durif; Alain Destée; Anne-Marie Bonnet; Christine Brefel-Courbon; Simon Heath; Diana Zelenika; Yves Agid; Alexandra Dürr; Alexis Brice
Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms.
Archives of neurology 2009;66(1):102-8.
2009: Gilbert Bensimon; Albert Ludolph; Yves Agid; Marie Vidailhet; Christine Payan; P Nigel Leigh
Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study.
Brain : a journal of neurology 2009;132(Pt 1):156-71.
2009: N Chastan; G W M Westby; Jérôme Yelnik; E Bardinet; Manh Cuong Do; Yves Agid; Marie-Laure Welter
Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.
Brain : a journal of neurology 2009;132(Pt 1):172-84.
2009: H El Otmani; N Jodoin; S Yaici; M-L Welter; Anne-Marie Bonnet; S Navarro; B Pidoux; D Dormont; P Cornu; Yves Agid
[Can subthalamic nucleus stimulation reveal parkinsonian rest tremor?].
Revue neurologique 2009;165(1):81-5.
2008: Luc Mallet; Mircea Polosan; Nematollah Jaafari; Nicolas Baup; Marie-Laure Welter; Denys Fontaine; Sophie Tezenas du Montcel; Jérôme Yelnik; Isabelle Chéreau; Christophe Arbus; Sylvie Raoul; Bruno Aouizerate; Philippe Damier; Stephan Chabardès; Virginie Czernecki; Claire Ardouin; Marie-Odile Krebs; Eric Bardinet; Patrick Chaynes; Pierre Burbaud; Philippe Cornu; Philippe Derost; Thierry Bougerol; Benoit Bataille; Vianney Mattei; Didier Dormont; Bertrand Devaux; Marc Vérin; Jean-Luc Houeto; Pierre Pollak; Alim-Louis Benabid; Yves Agid; Paul Krack; Bruno Millet; Antoine Pelissolo
Subthalamic nucleus stimulation in severe obsessive-compulsive disorder.
The New England journal of medicine 2008;359(20):2121-34.
2008: Fabrice Bonneville; Frédéric Bloch; Ewa Kurys; Sophie Tezenas du Montcel; Marie-Laure Welter; Anne-Marie Bonnet; Yves Agid; Didier Dormont; Jean-Luc Houeto
Camptocormia and Parkinson's disease: MR imaging.
European radiology 2008;18(8):1710-9.
2008: Marie-Laure Welter; Luc Mallet; Jean-Luc Houeto; Carine Karachi; Virginie Czernecki; Philippe Cornu; Soledad Navarro; Bernard Pidoux; Didier Dormont; Eric Bardinet; Jérôme Yelnik; Philippe Damier; Yves Agid
Internal pallidal and thalamic stimulation in patients with Tourette syndrome.
Archives of neurology 2008;65(7):952-7.
2008: Frédéric Sedel; Jean-Marie Saudubray; E Roze; Yves Agid; M Vidailhet
Movement disorders and inborn errors of metabolism in adults: a diagnostic approach.
Journal of inherited metabolic disease 2008;31(3):308-18.
2008: Virginie Czernecki; Michael Schüpbach; Sadek Yaici; Richard Lévy; Eric Bardinet; Jérôme Yelnik; Bruno Dubois; Yves Agid
Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom.
Movement disorders : official journal of the Movement Disorder Society 2008;23(7):964-9.
2008: M Y Frédéric; F Clot; L Cif; A Blanchard; A Dürr; I Vuillaume; G Lesca; A Kreisler; C Davin; T Besnard; F Rousset; D Thorel; C Saquet; D Mechin; L Ozelius; Yves Agid; B Barroso; B Chabrol; V Chan; M Clanet; C Coubes; Alain Destée; K Nguyen; C Vial; M Vidailhet; J Xie; B Sablonniere; A Calender; Alexis Brice; A Roubertie; P Coubes; M Claustres; S Tuffery-Giraud; G Collod-Beroud
Is the early-onset torsion dystonia (EOTD) linked to TOR1A gene as frequent as expected in France?
Neurogenetics 2008;9(2):143-50.
2008: Ebba Lohmann; Marie-Laure Welter; Valérie Fraix; Paul Krack; Suzanne Lesage; Sophie Laine; Marie-Laure Tanguy; Jean-Luc Houeto; Valérie Mesnage; Pierre Pollak; Alexandra Durr; Yves Agid; Alexis Brice
Are parkin patients particularly suited for deep-brain stimulation?
Movement disorders : official journal of the Movement Disorder Society 2008;23(5):740-3.
2008: W M Michael Schüpbach; Yves Agid
Psychosocial adjustment after deep brain stimulation in Parkinson's disease.
Nature clinical practice. Neurology 2008;4(2):58-9.
2008: C P Jedynak; K Youssov; E Apartis; M-L Welter; J-C Willer; Yves Agid
[Dystonia, tremor and repetitive instrumental use].
Revue neurologique 2008;164(1):53-60.
2008: Patric Blomstedt; Marwan I Hariz; Andrew J Lees; Paul Silberstein; Patricia Limousin; Jérôme Yelnik; Yves Agid
Acute severe depression induced by intraoperative stimulation of the substantia nigra: a case report.
Parkinsonism & related disorders 2008;14(3):253-6.
2007: Jean-Christophe Corvol; Jean-Baptiste Anzouan-Kacou; Elodie Fauveau; Anne-Marie Bonnet; Bénédicte Lebrun-Vignes; Camille Girault; Yves Agid; Philippe Lechat; Richard Isnard; Lucette Lacomblez
Heart valve regurgitation, pergolide use, and parkinson disease: an observational study and meta-analysis.
Archives of neurology 2007;64(12):1721-6.
2007: Laurent Vercueil; Jean-Luc Houeto; Pierre Krystkowiak; Christelle Lagrange; François Cassim; Abdelhamid Benazzouz; Bernard Pidoux; Alain Destée; Yves Agid; Philippe Cornu; Serge Blond; Alim-Louis Benabid; Pierre Pollak; Marie Vidailhet
Effects of pulse width variations in pallidal stimulation for primary generalized dystonia.
Journal of neurology 2007;254(11):1533-7.
2007: Jean-Luc Houeto; Jérôme Yelnik; Eric Bardinet; Laurent Vercueil; Pierre Krystkowiak; Valérie Mesnage; Christelle Lagrange; Dominique Dormont; Jean-François Le Bas; Jean-Pierre Pruvo; Sophie Tezenas du Montcel; Pierre Pollak; Yves Agid; Alain Destée; Marie Vidailhet
Acute deep-brain stimulation of the internal and external globus pallidus in primary dystonia: functional mapping of the pallidum.
Archives of neurology 2007;64(9):1281-6.
2007: Marie-Laure Welter; Manh Cuong Do; Nathalie Chastan; Frédéric Torny; Frédéric Bloch; Sophie Tezenas du Montcel; Yves Agid
Control of vertical components of gait during initiation of walking in normal adults and patients with progressive supranuclear palsy.
Gait & posture 2007;26(3):393-9.
2007: Luc Mallet; Michael Schüpbach; Karim NDIAYE; Philippe Remy; Eric Bardinet; Virginie Czernecki; Marie-Laure Welter; Antoine Pelissolo; Merle Ruberg; Yves Agid; Jérôme Yelnik
Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(25):10661-6.
2007: David Maltête; N Jodoin; Carine Karachi; Jean-Luc Houeto; Soledad Navarro; Philippe Cornu; Yves Agid; Marie-Laure Welter
Subthalamic stimulation and neuronal activity in the substantia nigra in Parkinson's disease.
Journal of neurophysiology 2007;97(6):4017-22.
2007: Suzanne Lesage; Sabine Janin; Ebba Lohmann; Anne-Louise Leutenegger; Laurence Leclere; François Viallet; Pierre Pollak; Franck Durif; Stéphane Thobois; Valérie Layet; Marie Vidailhet; Yves Agid; Alexandra Dürr; Alexis Brice; Anne-Marie Bonnet; Michel Borg; Emmanuel Broussolle; Philippe Damier; Alain Destée; Maria Martinez; Christiane Penet; Olivier Rasco; François Tison; Christine Tranchan; Marc Vérin
LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans.
Archives of neurology 2007;64(3):425-30.
2007: Yves Agid; György Buzsáki; David M Diamond; Richard S J Frackowiak; Jay Giedd; Jean-Antoine Girault; Anthony Grace; Jeremy J Lambert; Husseini K Manji; Helen S Mayberg; Maurizio Popoli; Alain Prochiantz; Gal Richter-Levin; Peter Somogyi; Michael Spedding; Per Svenningsson; Daniel Weinberger
How can drug discovery for psychiatric disorders be improved?
Nature reviews. Drug discovery 2007;6(3):189-201.
2007: Marie Vidailhet; Laurent Vercueil; Jean-Luc Houeto; Pierre Krystkowiak; Christelle Lagrange; Jérôme Yelnik; Eric Bardinet; Alim-Louis Benabid; Soledad Navarro; Dominique Dormont; Sylvie Grand; Serge Blond; Claire Ardouin; Bernard Pillon; Kathy Dujardin; Valerie Hahn-Barma; Yves Agid; Alain Destée; Pierre Pollak
Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study.
Lancet neurology 2007;6(3):223-9.
2007: Valérie Cochen De Cock; Marie Vidailhet; Smaranda Leu; Antonio Texeira; Emmanuelle Apartis; Alexis Elbaz; Emmanuel Roze; Jean Claude Willer; Jean-Philippe Derenne; Yves Agid; Isabelle Arnulf
Restoration of normal motor control in Parkinson's disease during REM sleep.
Brain : a journal of neurology 2007;130(Pt 2):450-6.
2007: W M M Schüpbach; David Maltête; Jean-Luc Houeto; Sophie Tezenas du Montcel; Luc Mallet; Marie-Laure Welter; Marcela Gargiulo; Cécile Béhar; Anne-Marie Bonnet; Virginie Czernecki; Bernard Pidoux; Soledad Navarro; Dominique Dormont; Philippe Cornu; Yves Agid
Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial.
Neurology 2007;68(4):267-71.
2007: Michael Schüpbach; Marie-Laure Welter; Anne-Marie Bonnet; Alexis Elbaz; Brandon R Grossardt; Valérie Mesnage; Jean-Luc Houeto; David Maltête; Luc Mallet; Walter A Rocca; Alain Mallet; Yves Agid
Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus.
Movement disorders : official journal of the Movement Disorder Society 2007;22(2):257-61.
2007: Jérôme Yelnik; Eric Bardinet; Dominique Dormont; Grégoire Malandain; Sébastien Ourselin; Dominique Tandé; Carine Karachi; Nicholas Ayache; Philippe Cornu; Yves Agid
A three-dimensional, histological and deformable atlas of the human basal ganglia. I. Atlas construction based on immunohistochemical and MRI data.
NeuroImage 2007;34(2):618-38.
2007: Michael Schüpbach; Ebba Lohmann; Mathieu Anheim; Suzanne Lesage; Virginie Czernecki; Sadek Yaici; Yulia Worbe; Perrine Charles; Marie-Laure Welter; Pierre Pollak; Alexandra Dürr; Yves Agid; Alexis Brice
Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations.
Movement disorders : official journal of the Movement Disorder Society 2007;22(1):119-22.
2006: Frédéric Sedel; M J Ribeiro; P Remy; N Blau; Jean-Marie Saudubray; Yves Agid
Dihydropteridine reductase deficiency: levodopa's long-term effectiveness without dyskinesia.
Neurology 2006;67(12):2243-5.
2006: Claire Ardouin; Valerie Voon; Yulia Worbe; Nehman Abouazar; Virginie Czernecki; Hassan Hosseini; Antoine Pelissolo; Elena Moro; Eugénie Lhommée; Anthony E Lang; Yves Agid; Alim-Louis Benabid; Pierre Pollak; Luc Mallet; Paul Krack
Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation.
Movement disorders : official journal of the Movement Disorder Society 2006;21(11):1941-6.
2006: Frédéric Bloch; Jean-Luc Houeto; Sophie Tezenas du Montcel; Fabrice Bonneville; Fabien Etchepare; Marie-Laure Welter; S Rivaud-Pechoux; Valerie Hahn-Barma; Thierry Maisonobe; Cécile Behar; Jean-Yves Lazennec; E Kurys; Isabelle Arnulf; Anne-Marie Bonnet; Yves Agid
Parkinson's disease with camptocormia.
Journal of neurology, neurosurgery, and psychiatry 2006;77(11):1223-8.
2006: Jean-Luc Houeto; Luc Mallet; Valérie Mesnage; Sophie Tezenas du Montcel; Cécile Béhar; Marcela Gargiulo; Frédéric Torny; Antoine Pelissolo; Marie-Laure Welter; Yves Agid
Subthalamic stimulation in Parkinson disease: behavior and social adaptation.
Archives of neurology 2006;63(8):1090-5.
2006: Michael Schüpbach; Marcela Gargiulo; Marie-Laure Welter; Luc Mallet; Cécile Béhar; Jean-Luc Houeto; David Maltête; Valérie Mesnage; Yves Agid
Neurosurgery in Parkinson disease: a distressed mind in a repaired body?
Neurology 2006;66(12):1811-6.
2006: Maria Fiorella Contarino; Marie Laure Welter; Yves Agid; Andreas Hartmann
Orthostatic tremor in monozygotic twins.
Neurology 2006;66(10):1600-1.
2006: Bernard Pillon; Claire Ardouin; Kathy Dujardin; P Vittini; Antoine Pelissolo; Olivier Cottencin; Laurent Vercueil; Jean-Luc Houeto; Pierre Krystkowiak; Yves Agid; Alain Destée; Pierre Pollak; Marie Vidailhet
Preservation of cognitive function in dystonia treated by pallidal stimulation.
Neurology 2006;66(10):1556-8.
2006: Fabien Etchepare; sylvie rozenberg; Tristan Mirault; Anne-Marie Bonnet; Colette Lecorre; Yves Agid; Pierre Bourgeois; Bruno Fautrel
Back problems in Parkinson's disease: an underestimated problem.
Joint, bone, spine : revue du rhumatisme 2006;73(3):298-302.
2006: Pablo Ibáñez; Suzanne Lesage; Ebba Lohmann; Stéphane Thobois; Giuseppe De Michele; Michel Borg; Yves Agid; Alexandra Dürr; Alexis Brice
Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa.
Brain : a journal of neurology 2006;129(Pt 3):686-94.
2006: Yves Agid; Michael Schüpbach; Marcela Gargiulo; Luc Mallet; Jean-Luc Houeto; Cécile Behar; David Maltête; Valérie Mesnage; Marie-Laure Welter
Neurosurgery in Parkinson's disease: the doctor is happy, the patient less so?
Journal of neural transmission. Supplementum 2006;(70):409-14.
2006: Frédéric Sedel; Karen H Friderici; Katherine Nummy; Catherine Caillaud; Allel Chabli; Alexandra Dürr; Catherine Lubetzki; Yves Agid
Atypical Gilles de la Tourette Syndrome with beta-mannosidase deficiency.
Archives of neurology 2006;63(1):129-31.
2005: Mathias Pessiglione; Virginie Czernecki; Bernard Pillon; Bruno Dubois; Michael Schüpbach; Yves Agid; Léon Tremblay
An effect of dopamine depletion on decision-making: the temporal coupling of deliberation and execution.
Journal of cognitive neuroscience 2005;17(12):1886-96.
2005: W M M Schüpbach; N Chastan; Marie-Laure Welter; Jean-Luc Houeto; Valérie Mesnage; Anne-Marie Bonnet; Virginie Czernecki; David Maltête; A Hartmann; Luc Mallet; Bernard Pidoux; Dominique Dormont; Soledad Navarro; Philippe Cornu; Alain Mallet; Yves Agid
Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up.
Journal of neurology, neurosurgery, and psychiatry 2005;76(12):1640-4.
2005: Suzanne Lesage; Pablo Ibanez; Ebba Lohmann; Pierre Pollak; François Tison; Meriem Tazir; Anne-Louise Leutenegger; Joao Guimaraes; Anne-Marie Bonnet; Yves Agid; Alexandra Dürr; Alexis Brice
G2019S LRRK2 mutation in French and North African families with Parkinson's disease.
Annals of neurology 2005;58(5):784-7.
2005: Stephan Klebe; Alexandra Durr; Alexander Rentschler; Valerie Hahn-Barma; Michael Abele; Naima Bouslam; Ludger Schöls; Pierre Jedynak; Sylvie Forlani; Elodie Denis; Christel Dussert; Yves Agid; Peter Bauer; Christoph Globas; Ullrich Wüllner; Alexis Brice; Olaf Riess; Giovanni Stevanin
New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14.
Annals of neurology 2005;58(5):720-9.
2005: Maria C Rodriguez-Oroz; Jose A Obeso; Anthony E Lang; Jean-Luc Houeto; Pierre Pollak; Stig Rehncrona; Jaime Kulisevsky; Alberto Albanese; Jens Volkmann; Marwan I Hariz; Niall Quinn; Johannes D Speelman; Jorge Guridi; Ivana Zamarbide; Alexandre Gironell; Joan Molet; Berta Pascual-Sedano; Bernard Pidoux; Anne-Marie Bonnet; Yves Agid; J Xie; Alim-Louis Benabid; Andres M Lozano; J Saint-Cyr; Luigi Romito; Maria Fiorella Contarino; Massimo Scerrati; Valérie Fraix; Nadège Van Blercom
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
Brain : a journal of neurology 2005;128(Pt 10):2240-9.
2005: Jean-Luc Houeto; Carine Karachi; Luc Mallet; Bernard Pillon; Jérôme Yelnik; Valérie Mesnage; Marie-Laure Welter; Soledad Navarro; Antoine Pelissolo; Philippe Damier; Bernard Pidoux; Dominique Dormont; Philippe Cornu; Yves Agid
Tourette's syndrome and deep brain stimulation.
Journal of neurology, neurosurgery, and psychiatry 2005;76(7):992-5.
2005: Virginie Czernecki; Bernard Pillon; Jean-Luc Houeto; Marie-Laure Welter; Valérie Mesnage; Yves Agid; Bruno Dubois
Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?
Journal of neurology, neurosurgery, and psychiatry 2005;76(6):775-9.
2005: Fabrice Bonneville; Marie-Laure Welter; C Elie; Sophie Tezenas du Montcel; Dominique Hasboun; Carole Menuel; Jean-Luc Houeto; Anne-Marie Bonnet; Valérie Mesnage; Bernard Pidoux; Soledad Navarro; Philippe Cornu; Yves Agid; Dominique Dormont
Parkinson disease, brain volumes, and subthalamic nucleus stimulation.
Neurology 2005;64(9):1598-604.
2005: Morgane Caer; Karine Viala; Richard Levy; Thierry Maisonobe; Florence Chochon; Agnès Lombès; Yves Agid
Adult-onset chorea and mitochondrial cytopathy.
Movement disorders : official journal of the Movement Disorder Society 2005;20(4):490-2.
2005: Isabelle Arnulf; Milagros Merino-Andreu; Frédéric Bloch; Eric Konofal; Marie Vidailhet; Valérie Cochen; Jean-Philippe Derenne; Yves Agid
REM sleep behavior disorder and REM sleep without atonia in patients with progressive supranuclear palsy.
Sleep 2005;28(3):349-54.
2005: Marie Vidailhet; Laurent Vercueil; Jean-Luc Houeto; Pierre Krystkowiak; Alim-Louis Benabid; Philippe Cornu; Christelle Lagrange; Sophie Tezenas du Montcel; Dominique Dormont; Sylvie Grand; Serge Blond; Olivier Detante; Bernard Pillon; Claire Ardouin; Yves Agid; Alain Destée; Pierre Pollak
Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia.
The New England journal of medicine 2005;352(5):459-67.
2005: Eric Bardinet; Dominique Dormont; Grégoire Malandain; Manik Bhattacharjee; Bernard Pidoux; Christian Saleh; Philippe Cornu; Nicholas Ayache; Yves Agid; Jérôme Yelnik
Retrospective cross-evaluation of an histological and deformable 3D atlas of the basal ganglia on series of Parkinsonian patients treated by deep brain stimulation.
Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention 2005;8(Pt 2):385-93.
2005: David J Brooks; Yves Agid; Karla Eggert; Håkan Widner; K Ostergaard; A Holopainen
Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment.
European neurology 2005;53(4):197-202.
2004: Alexandre Kreisler; Bruno Stankoff; Maria João Ribeiro; Yves Agid; Catherine Lubetzki; Bertrand Fontaine
Unexpected aggravation of Parkinson's disease by a mesencephalic multiple sclerosis lesion.
Journal of neurology 2004;251(12):1526-7.
2004: Dominique Dormont; Kenneth G Ricciardi; Dominique Tandé; Karine Parain; Carole Menuel; Damien Galanaud; Soledad Navarro; Philippe Cornu; Yves Agid; Jérôme Yelnik
Is the subthalamic nucleus hypointense on T2-weighted images? A correlation study using MR imaging and stereotactic atlas data.
AJNR. American journal of neuroradiology 2004;25(9):1516-23.
2004: Pablo Ibáñez; Anne-Marie Bonnet; B Débarges; Ebba Lohmann; François Tison; Pierre Pollak; Yves Agid; Alexandra Dürr; Alexis Brice
Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease.
Lancet 2004;364(9440):1169-71.
2004: F Turny; Pierre Jedynak; Yves Agid
[Athetosis or dystonia?].
Revue neurologique 2004;160(8-9):759-64.
2004: C Warren Olanow; Yves Agid; Yoshikuni Mizuno; Alberto Albanese; Ubaldo Bonuccelli; U Bonucelli; Philippe Damier; Justo De Yebenes; Oscar S Gershanik; Mark Guttman; Francisco Grandas; Mark Hallett; Oleh Hornykiewicz; Peter Jenner; Regina Katzenschlager; William J Langston; Peter LeWitt; Eldad Melamed; M A Mena; Patrick P Michel; Catherine Mytilineou; Jose A Obeso; Werner Poewe; Niall Quinn; Rita Raisman-Vozari; Ali H Rajput; Olivier Rascol; Cristina Sampaio; Fabrizio Stocchi
Levodopa in the treatment of Parkinson's disease: current controversies.
Movement disorders : official journal of the Movement Disorder Society 2004;19(9):997-1005.
2004: David Grabli; McCairn Kevin; Etienne C Hirsch; Yves Agid; Jean Féger; Chantal François; Léon Tremblay
Behavioural disorders induced by external globus pallidus dysfunction in primates: I. Behavioural study.
Brain : a journal of neurology 2004;127(Pt 9):2039-54.
2004: Pierre Payoux; Philippe Remy; Philippe Damier; Malika Miloudi; Isabelle Loubinoux; Bernard Pidoux; Véronique Gaura; Olivier Rascol; Yves Samson; Yves Agid
Subthalamic nucleus stimulation reduces abnormal motor cortical overactivity in Parkinson disease.
Archives of neurology 2004;61(8):1307-13.
2004: Pierre Jedynak; Yves Agid
Primary orthostatic tremor and unsteadiness.
Movement disorders : official journal of the Movement Disorder Society 2004;19(8):989.
2004: Pablo Ibáñez; Ebba Lohmann; Pierre Pollak; Franck Durif; Christine Tranchant; Yves Agid; Alexandra Dürr; Alexis Brice
Absence of NR4A2 exon 1 mutations in 108 families with autosomal dominant Parkinson disease.
Neurology 2004;62(11):2133-4.
2004: Valérie Mesnage; Jean-Luc Houeto; Anne-Marie Bonnet; I Clavier; Isabelle Arnulf; F Cattelin; G Le Fur; Philippe Damier; Marie-Laure Welter; Yves Agid
Neurokinin B, neurotensin, and cannabinoid receptor antagonists and Parkinson disease.
Clinical neuropharmacology 2004;27(3):108-10.
2004: Isabelle Le Ber; Naima Bouslam; Sophie Rivaud-Péchoux; João Guimarães; Ali Benomar; Céline Chamayou; Cyril Goizet; Maria-Ceù Moreira; Sandra Klur; Mohamed Yahyaoui; Yves Agid; Michel Koenig; Giovanni Stevanin; Alexis Brice; Alexandra Dürr
Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: a clinical and genetic study in 18 patients.
Brain : a journal of neurology 2004;127(Pt 4):759-67.
2004: David Maltête; Soledad Navarro; Marie-Laure Welter; Sabine Roche; Anne-Marie Bonnet; Jean-Luc Houeto; Valérie Mesnage; Bernard Pidoux; Dominique Dormont; Philippe Cornu; Yves Agid
Subthalamic stimulation in Parkinson disease: with or without anesthesia?
Archives of neurology 2004;61(3):390-2.
2004: Marie-Laure Welter; Jean-Luc Houeto; Anne-Marie Bonnet; Paul-Boulos Bejjani; Valérie Mesnage; Dominique Dormont; Soledad Navarro; Philippe Cornu; Yves Agid; Bernard Pidoux
Effects of high-frequency stimulation on subthalamic neuronal activity in parkinsonian patients.
Archives of neurology 2004;61(1):89-96.
2003: Bechir Jarraya; Anne-Marie Bonnet; Charles Duyckaerts; Jean-Luc Houeto; Philippe Cornu; JEAN-JACQUES HAUW; Yves Agid
Parkinson's disease, subthalamic stimulation, and selection of candidates: a pathological study.
Movement disorders : official journal of the Movement Disorder Society 2003;18(12):1517-20.
2003: Pablo Ibáñez; Giuseppe De Michele; Vincenzo Bonifati; Ebba Lohmann; Stéphane Thobois; Pierre Pollak; Yves Agid; Peter Heutink; Alexandra Dürr; Alexis Brice
Screening for DJ-1 mutations in early onset autosomal recessive parkinsonism.
Neurology 2003;61(10):1429-31.
2003: Christoph B Lücking; Véronique Chesneau; Ebba Lohmann; Patrice Verpillat; Cyprien Dulac; Anne-Marie Bonnet; Francesca Gasparini; Yves Agid; Alexandra Dürr; Alexis Brice
Coding polymorphisms in the parkin gene and susceptibility to Parkinson disease.
Archives of neurology 2003;60(9):1253-6.
2003: Baptiste A Faucheux; Marie-Elise Martin; Carole Beaumont; JEAN-JACQUES HAUW; Yves Agid; Etienne C Hirsch
Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease.
Journal of neurochemistry 2003;86(5):1142-8.
2003: Ebba Lohmann; Magali Periquet; Vincenzo Bonifati; Nicholas W Wood; Giuseppe De Michele; Anne-Marie Bonnet; Valérie Fraix; Emmanuel Broussolle; Martin Horstink; Marie Vidailhet; Patrice Verpillat; Thomas Gasser; David Nicholl; Hélio A G Teive; Salmo Raskin; Olivier Rascol; Alain Destée; Merle Ruberg; Francesca Gasparini; Giuseppe Meco; Yves Agid; Alexandra Durr; Alexis Brice
How much phenotypic variation can be attributed to parkin genotype?
Annals of neurology 2003;54(2):176-85.
2003: Emmanuelle Waubant; Sophie Tezenas du Montcel; Charles Jedynak; Michaël Obadia; Hassan Hosseini; Philippe Damier; Catherine Lubetzki; Yves Agid; Jean-Denis Degos
Multiple sclerosis tremor and the Stewart-Holmes manoeuvre.
Movement disorders : official journal of the Movement Disorder Society 2003;18(8):948-52.
2003: Jean-Philippe Brandel; Michael Preece; Paul Brown; Esther Croes; Jean-Louis Laplanche; Yves Agid; Robert Will; Annick Alpérovitch
Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK.
Lancet 2003;362(9378):128-30.
2003: Jérôme Yelnik; Philippe Damier; Sophie Demeret; David Gervais; Eric Bardinet; Boulos-Paul Bejjani; Chantal François; Jean-Luc Houeto; Isabelle Arnule; Dominique Dormont; Damien Galanaud; Bernard Pidoux; Philippe Cornu; Yves Agid
Localization of stimulating electrodes in patients with Parkinson disease by using a three-dimensional atlas-magnetic resonance imaging coregistration method.
Journal of neurosurgery 2003;99(1):89-99.
2003: Mathias Pessiglione; Dominique Guehl; Yves Agid; Etienne C Hirsch; Jean Féger; Léon Tremblay
Impairment of context-adapted movement selection in a primate model of presymptomatic Parkinson's disease.
Brain : a journal of neurology 2003;126(Pt 6):1392-408.
2003: Magali Periquet; Morwena Latouche; Ebba Lohmann; Nina Rawal; Giuseppe De Michele; Sylvain Ricard; Hélio A G Teive; Valérie Fraix; Marie Vidailhet; David Nicholl; Paolo Barone; Nicholas W Wood; Salmo Raskin; Jean-François Deleuze; Yves Agid; Alexandra Dürr; Alexis Brice
Parkin mutations are frequent in patients with isolated early-onset parkinsonism.
Brain : a journal of neurology 2003;126(Pt 6):1271-8.
2003: Milagros Merino-Andreu; Isabelle Arnulf; Eric Konofal; Jean-Philippe Derenne; Yves Agid
Unawareness of naps in Parkinson's disease and in disorders with excessive daytime sleepiness.
Neurology 2003;60(9):1553-4.
2003: Stéphane Thobois; Maria-João Ribeiro; Ebba Lohmann; Alexandra Dürr; Pierre Pollak; Olivier Rascol; Stephane Guillouet; Elizabeth Chapoy; Nicolas Costes; Yves Agid; Philippe Remy; Alexis Brice; Emmanuel Broussolle
Young-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study.
Archives of neurology 2003;60(5):713-8.
2003: Jean-Luc Houeto; Marie-Laure Welter; Paul-Boulos Bejjani; Sophie Tezenas du Montcel; Anne-Marie Bonnet; Valérie Mesnage; Soledad Navarro; Bernard Pidoux; Dominique Dormont; Philippe Cornu; Yves Agid
Subthalamic stimulation in Parkinson disease: intraoperative predictive factors.
Archives of neurology 2003;60(5):690-4.
2003: Nina Rawal; Magali Periquet; Ebba Lohmann; Christoph B Lücking; Hélio A G Teive; G Ambrosio; Salmo Raskin; Sarah J Lincoln; Nobutaka Hattori; Joao Guimaraes; Martin Horstink; W Dos Santos Bele; E Brousolle; Alain Destée; Yoshikuni Mizuno; Matthew J Farrer; Jean-François Deleuze; Giuseppe De Michele; Yves Agid; Alexandra Dürr; Alexis Brice
New parkin mutations and atypical phenotypes in families with autosomal recessive parkinsonism.
Neurology 2003;60(8):1378-81.
2003: Yves Agid
[Address from the president of French Society of Neurologists for 2002].
Revue neurologique 2003;159(3):332-3.
2003: Emmanuel Gerardin; Stéphane Lehéricy; Jean-Baptiste Pochon; Sophie Tezenas du Montcel; jean-francois mangin; Fabrice Poupon; Yves Agid; Denis Le Bihan; Claude Marsault
Foot, hand, face and eye representation in the human striatum.
Cerebral cortex (New York, N.Y. : 1991) 2003;13(2):162-9.
2003: Jean-Luc Houeto; Valérie Mesnage; Marie-Laure Welter; Luc Mallet; Yves Agid; Boulos-Paul Bejjani
Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up.
Neurology 2003;60(1):154-5; author reply 154-5.
2003: C Warren Olanow; Anthony H V Schapira; Yves Agid
Neuroprotection for Parkinson's disease: prospects and promises.
Annals of neurology 2003;53 Suppl 3():S1-2.
2003: Yves Agid; Isabelle Arnulf; Paul-Boulos Bejjani; Frédéric Bloch; Anne-Marie Bonnet; Philippe Damier; Bruno Dubois; Chantal François; Jean-Luc Houeto; D Iacono; Carine Karachi; Valérie Mesnage; O Messouak; Marie Vidailhet; Marie-Laure Welter; Jérôme Yelnik
Parkinson's disease is a neuropsychiatric disorder.
Advances in neurology 2003;91():365-70.
2002: Patrick P Michel; Etienne C Hirsch; Yves Agid
[Parkinson disease: mechanisms of cell death].
Revue neurologique 2002;158 Spec no 1():S24-32.
2002: Valérie Mesnage; Jean-Luc Houeto; Marie-Laure Welter; Yves Agid; Bernard Pidoux; D Dormont; Philippe Cornu
Parkinson's disease: neurosurgery at an earlier stage?
Journal of neurology, neurosurgery, and psychiatry 2002;73(6):778-9.
2002: Boulos-Paul Bejjani; Jean-Luc Houeto; Marwan I Hariz; Jérôme Yelnik; Valérie Mesnage; Anne-Marie Bonnet; Bernard Pidoux; Dominique Dormont; Philippe Cornu; Yves Agid
Aggressive behavior induced by intraoperative stimulation in the triangle of Sano.
Neurology 2002;59(9):1425-7.
2002: Luc Mallet; Valérie Mesnage; Jean-Luc Houeto; Antoine Pelissolo; Jérôme Yelnik; Cécile Behar; Marcela Gargiulo; Marie-Laure Welter; Anne-Marie Bonnet; Bernard Pillon; Philippe Cornu; Dominique Dormont; Bernard Pidoux; Jean-François Allilaire; Yves Agid
Compulsions, Parkinson's disease, and stimulation.
Lancet 2002;360(9342):1302-4.
2002: Baptiste A Faucheux; Marie-Elise Martin; Carole Beaumont; Stéphane Hunot; JEAN-JACQUES HAUW; Yves Agid; Etienne C Hirsch
Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease.
Journal of neurochemistry 2002;83(2):320-30.
2002: Sheela Vyas; Nicole Faucon Biguet; Patrick P Michel; Lucia Monaco; Nicholas S Foulkes; Gerard I Evan; Paolo Sassone-Corsi; Yves Agid
Molecular mechanisms of neuronal cell death: implications for nuclear factors responding to cAMP and phorbol esters.
Molecular and cellular neurosciences 2002;21(1):1-14.
2002: Yves Agid; C Warren Olanow; Yoshikuni Mizuno
Levodopa: why the controversy?
Lancet 2002;360(9332):575.
2002: Nina Rawal; Magali Periquet; Alexandra Dürr; Giuseppe De Michele; Vincenzo Bonifati; Hélio A G Teive; Salmo Raskin; Joao Guimaraes; Yves Agid; Alexis Brice
Exclusion of the Nurr1 gene in autosomal recessive Parkinson's disease.
Journal of neurology 2002;249(8):1127-9.
2002: Claire Borie; Francesca Gasparini; Patrice Verpillat; Anne-Marie Bonnet; Yves Agid; Gilles Hetet; Alexis Brice; Alexandra Dürr; Bernard Grandchamp
Association study between iron-related genes polymorphisms and Parkinson's disease.
Journal of neurology 2002;249(7):801-4.
2002: Aicha Douhou; Thomas Debeir; M Gustavo Murer; Louis Do; Noëlle Dufour; Véronique Blanchard; Saliha Moussaoui; Georg Andrees Bohme; Yves Agid; Rita Raisman-Vozari
Effect of chronic treatment with riluzole on the nigrostriatal dopaminergic system in weaver mutant mice.
Experimental neurology 2002;176(1):247-53.
2002: Jean-Luc Houeto; Valérie Mesnage; Luc Mallet; Bernard Pillon; Marcela Gargiulo; Sophie Tezenas du Montcel; Anne-Marie Bonnet; Bernard Pidoux; Dominique Dormont; Philippe Cornu; Yves Agid
Behavioural disorders, Parkinson's disease and subthalamic stimulation.
Journal of neurology, neurosurgery, and psychiatry 2002;72(6):701-7.
2002: Isabelle Arnulf; Eric Konofal; Milagros Merino-Andreu; Jean-Luc Houeto; Valérie Mesnage; Marie-Laure Welter; L Lacomblez; J L Golmard; Jean-Philippe Derenne; Yves Agid
Parkinson's disease and sleepiness: an integral part of PD.
Neurology 2002;58(7):1019-24.
2002: Boulos-Paul Bejjani; Isabelle Arnulf; Jean-Luc Houeto; D Milea; Sophie Demeret; Bernard Pidoux; Philippe Damier; Philippe Cornu; Dominique Dormont; Yves Agid
Concurrent excitatory and inhibitory effects of high frequency stimulation: an oculomotor study.
Journal of neurology, neurosurgery, and psychiatry 2002;72(4):517-22.
2002: Pierre Labauge; L O Amer; Marion Simonetta-Moreau; F Attané; C Tannier; Michel Clanet; Giovanni Castelnovo; I An-Gourfinkel; Yves Agid; Alexis Brice; Anne Ducros; Eric LeGuern
Absence of linkage to 8q24 in a European family with familial adult myoclonic epilepsy (FAME).
Neurology 2002;58(6):941-4.
2002: Marie-Laure Welter; Jean-Luc Houeto; Sophie Tezenas du Montcel; Valérie Mesnage; Anne-Marie Bonnet; Bernard Pillon; Isabelle Arnulf; Bernard Pidoux; Dominique Dormont; Philippe Cornu; Yves Agid
Clinical predictive factors of subthalamic stimulation in Parkinson's disease.
Brain : a journal of neurology 2002;125(Pt 3):575-83.
2002: Isabelle Gourfinkel-An; Miquel Vila; Baptiste A Faucheux; Charles Duyckaerts; François Viallet; JEAN-JACQUES HAUW; Alexis Brice; Yves Agid; Etienne C Hirsch
Metabolic changes in the basal ganglia of patients with Huntington's disease: an in situ hybridization study of cytochrome oxidase subunit I mRNA.
Journal of neurochemistry 2002;80(3):466-76.
2002: Andreas Hartmann; Annick Mouatt-Prigent; Baptiste A Faucheux; Yves Agid; Etienne C Hirsch
FADD: A link between TNF family receptors and caspases in Parkinson's disease.
Neurology 2002;58(2):308-10.
2001: E Waubant; P Alizé; Ayman Tourbah; Yves Agid
Paroxysmal dystonia (tonic spasm) in multiple sclerosis.
Neurology 2001;57(12):2320-1.
2001: Yves Agid
Levodopa. Is toxicity a myth? 1998.
Neurology 2001;57(10 Suppl 3):S46-51.
2001: Concepció Marin; Anna Jiménez; Mercè Bonastre; Miquel Vila; Yves Agid; Etienne C Hirsch; Eduardo Tolosa
LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in Parkinsonian rats.
Synapse (New York, N.Y.) 2001;42(1):40-7.
2001: Stéphane Lehéricy; Sylvie Grand; Pierre Pollak; Fabrice Poupon; Jean-François Le Bas; Patricia Limousin; Pierre Jedynak; Claude Marsault; Yves Agid; Marie Vidailhet
Clinical characteristics and topography of lesions in movement disorders due to thalamic lesions.
Neurology 2001;57(6):1055-66.
2001: Olivier Rascol; Isabelle Arnulf; H Peyro-Saint-Paul; Christine Brefel-Courbon; M Vidailhet; Claire Thalamas; Anne-Marie Bonnet; Sylvie Descombes; B Bejjani; Nelly Fabre; Jean-Louis Montastruc; Yves Agid
Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2001;16(4):708-13.
2001: Patrice Verpillat; S Bouley; Dominique Campion; Didier Hannequin; Bruno Dubois; Serge Belliard; Michèle Puel; Catherine Thomas-Antérion; Yves Agid; Alexis Brice; Françoise Clerget-Darpoux
Use of haplotype information to test involvement of the LRP gene in Alzheimer's disease in the French population.
European journal of human genetics : EJHG 2001;9(6):464-8.
2001: Isabelle Arnulf; M Vidailhet; Anne-Marie Bonnet; Sylvie Descombes; C Jaillon; Yves Agid; C Brefel; Olivier Rascol; J Xie; Pierre Pollak; F Cattelin
Blockade of cholecystokinin-A receptors has no effect on dyskinesias in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 2001;70(6):812-3.
2001: Sylvie Descombes; Anne-Marie Bonnet; UE Gasser; Claire Thalamas; J Dingemanse; Isabelle Arnulf; M P Bareille; Yves Agid; Olivier Rascol
Dual-release formulation, a novel principle in L-dopa treatment of Parkinson's disease.
Neurology 2001;56(9):1239-42.
2001: Marie Vidailhet; JP Tassin; Franck Durif; A Nivelon-Chevallier; Yves Agid; Alexis Brice; Alexandra Dürr
A major locus for several phenotypes of myoclonus--dystonia on chromosome 7q.
Neurology 2001;56(9):1213-6.
2001: Marie-Paule Muriel; Yves Agid; Etienne C Hirsch
Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2001;16(3):435-41.
2001: Mohammed Bensaid; B A Faucheux; Etienne C Hirsch; Yves Agid; Philippe Soubrié; Florence Oury-Donat
Expression of tachykinin NK2 receptor mRNA in human brain.
Neuroscience letters 2001;303(1):25-8.
2001: M Zarate-Lagunes; Wen-Jie Gu; Véronique Blanchard; C Francois; Marie-Paule Muriel; Annick Mouatt-Prigent; Bruno Bonici; A Parent; Andreas Hartmann; Jérôme Yelnik; G A Boehme; Laurent Pradier; Saliha Moussaoui; Baptiste A Faucheux; Rita Raisman-Vozari; Yves Agid; Alexis Brice; Etienne C Hirsch
Parkin immunoreactivity in the brain of human and non-human primates: an immunohistochemical analysis in normal conditions and in Parkinsonian syndromes.
The Journal of comparative neurology 2001;432(2):184-96.
2001: Andreas Hartmann; jean-denis troadec; Stéphane Hunot; K Kikly; Baptiste A Faucheux; Annick Mouatt-Prigent; Merle Ruberg; Yves Agid; Etienne C Hirsch
Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2001;21(7):2247-55.
2001: H Turmel; Andreas Hartmann; Karine Parain; Aicha Douhou; A Srinivasan; Yves Agid; Etienne C Hirsch
Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
Movement disorders : official journal of the Movement Disorder Society 2001;16(2):185-9.
2001: Andreas Hartmann; Patrick P Michel; jean-denis troadec; Annick Mouatt-Prigent; Baptiste A Faucheux; Merle Ruberg; Yves Agid; Etienne C Hirsch
Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?
Journal of neurochemistry 2001;76(6):1785-93.
2001: Magali Periquet; C Lücking; J Vaughan; Vincenzo Bonifati; Alexandra Dürr; Giuseppe De Michele; Martin Horstink; Matthew J Farrer; Sergei N Illarioshkin; Pierre Pollak; M Borg; C Brefel-Courbon; Patrice DENEFLE; Giuseppe Meco; Thomas Gasser; Monique Breteler; Nicholas W Wood; Yves Agid; Alexis Brice
Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects.
American journal of human genetics 2001;68(3):617-26.
2001: Vincenzo Bonifati; Giuseppe De Michele; Christoph B Lücking; Alexandra Dürr; Edito Fabrizio; G Ambrosio; Nicola Vanacore; Michele De Mari; Roberto Marconi; L Capus; Monique Breteler; Thomas Gasser; Ben A Oostra; Nicholas W Wood; Yves Agid; Alessandro Filla; Giuseppe Meco; Alexis Brice
The parkin gene and its phenotype. Italian PD Genetics Study Group, French PD Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2001;22(1):51-2.
2001: Jean-Philippe Brandel; Katell Peoc'h; Patrice Beaudry; A Welaratne; C Bottos; Yves Agid; Jean-Louis Laplanche
14-3-3 protein cerebrospinal fluid detection in human growth hormone-treated Creutzfeldt-Jakob disease patients.
Annals of neurology 2001;49(2):257-60.
2001: Nathalie Lambeng; Patrick P Michel; Yves Agid; Merle Ruberg
The relationship between differentiation and survival in PC12 cells treated with cyclic adenosine monophosphate in the presence of epidermal growth factor or nerve growth factor.
Neuroscience letters 2001;297(2):133-6.
2001: Philippe Damier; Jean-Luc Houeto; Boulos-Paul Bejjani; Isabelle Arnulf; Anne-Marie Bonnet; M Miloudy; Yves Agid
The role of the pallidum in Parkinson's disease gait. Lessons from pallidal stimulation.
Advances in neurology 2001;87():283-8.
2000: Isabelle Arnulf; Boulos-Paul Bejjani; L Garma; Anne-Marie Bonnet; Jean-Luc Houeto; Philippe Damier; Jean-Philippe Derenne; Yves Agid
Improvement of sleep architecture in PD with subthalamic nucleus stimulation.
Neurology 2000;55(11):1732-4.
2000: Caroline Jan; Chantal François; Dominique Tandé; Jérôme Yelnik; Léon Tremblay; Yves Agid; Etienne C Hirsch
Dopaminergic innervation of the pallidum in the normal state, in MPTP-treated monkeys and in parkinsonian patients.
The European journal of neuroscience 2000;12(12):4525-35.
2000: G Cancel; Charles Duyckaerts; M Holmberg; Cecilia Zander; Gaël Yvert; Anne-Sophie Lebre; Merle Ruberg; Baptiste A Faucheux; Yves Agid; Etienne C Hirsch; Alexis Brice
Distribution of ataxin-7 in normal human brain and retina.
Brain : a journal of neurology 2000;123 Pt 12():2519-30.
2000: Emmanuel Gerardin; Angela Sirigu; Stéphane Lehéricy; Jean-Baptiste Poline; B Gaymard; Claude Marsault; Yves Agid; Denis Le Bihan
Partially overlapping neural networks for real and imagined hand movements.
Cerebral cortex (New York, N.Y. : 1991) 2000;10(11):1093-104.
2000: Marie-Paule Muriel; Nathalie Lambeng; Frédéric Darios; Patrick P Michel; Etienne C Hirsch; Yves Agid; Merle Ruberg
Mitochondrial free calcium levels (Rhod-2 fluorescence) and ultrastructural alterations in neuronally differentiated PC12 cells during ceramide-dependent cell death.
The Journal of comparative neurology 2000;426(2):297-315.
2000: Etienne C Hirsch; Celine Perier; Gaël Orieux; Chantal François; Jean Féger; Jérôme Yelnik; Miquel Vila; R Levy; Eduardo Tolosa; Concepció Marin; M Trinidad Herrero; Jose A Obeso; Yves Agid
Metabolic effects of nigrostriatal denervation in basal ganglia.
Trends in neurosciences 2000;23(10 Suppl):S78-85.
2000: Pierre Dubus; Baptiste A Faucheux; F Boissière; A Groppi; C Vital; A Vital; Yves Agid; Etienne C Hirsch; Jean-Philippe Merlio
Expression of Trk isoforms in brain regions and in the striatum of patients with Alzheimer's disease.
Experimental neurology 2000;165(2):285-94.
2000: Celine Perier; Yves Agid; Etienne C Hirsch; Jean Féger
Ipsilateral and contralateral subthalamic activity after unilateral dopaminergic lesion.
Neuroreport 2000;11(14):3275-8.
2000: Jean-Luc Houeto; Paul-Boulos Bejjani; Philippe Damier; C Staedler; Anne-Marie Bonnet; Bernard Pidoux; Dominique Dormont; Philippe Cornu; Yves Agid
Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PD.
Neurology 2000;55(5):728-30.
2000: Boulos-Paul Bejjani; Isabelle Arnulf; Marie Vidailhet; Bernard Pidoux; Philippe Damier; S Papadopoulos; Anne-Marie Bonnet; Philippe Cornu; Dominique Dormont; Yves Agid
Irregular jerky tremor, myoclonus, and thalamus: a study using low-frequency stimulation.
Movement disorders : official journal of the Movement Disorder Society 2000;15(5):919-24.
2000: Patrice Verpillat; S Bouley; Didier Hannequin; Serge Belliard; Michèle Puel; Catherine Thomas-Anterion; Bruno Dubois; Yves Agid; Dominique Campion; Françoise Clerget-Darpoux; Alexis Brice
Alpha2-macroglobulin gene and Alzheimer's disease: confirmation of association by haplotypes analyses.
Annals of neurology 2000;48(3):400-2.
2000: Bernard Pillon; Claire Ardouin; Philippe Damier; Paul Krack; Jean-Luc Houeto; H Klinger; Anne-Marie Bonnet; Pierre Pollak; Alim-Louis Benabid; Yves Agid
Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease.
Neurology 2000;55(3):411-8.
2000: Isabelle Arnulf; Anne-Marie Bonnet; Philippe Damier; Boulos-Paul Bejjani; D Seilhean; Jean-Philippe Derenne; Yves Agid
Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis.
Neurology 2000;55(2):281-8.
2000: Gerhard Ransmayr; Baptiste A Faucheux; C Nowakowski; N Kubis; S Federspiel; W Kaufmann; D Henin; JEAN-JACQUES HAUW; Yves Agid; Etienne C Hirsch
Age-related changes of neuronal counts in the human pedunculopontine nucleus.
Neuroscience letters 2000;288(3):195-8.
2000: Alexandra Dürr; JP Tassin; Marie Vidailhet; Franck Durif; Pierre Jedynak; Yves Agid; Alexis Brice
D2 dopamine receptor gene in myoclonic dystonia and essential myoclonus.
Annals of neurology 2000;48(1):127-8.
2000: JP Tassin; Alexandra Dürr; Anne-Marie Bonnet; R Gil; Marie Vidailhet; Christoph B Lücking; J Y Goas; Franck Durif; M Abada; Bernard Echenne; Jacques Motte; A Lagueny; Lucette Lacomblez; Pierre Jedynak; B Bartholomé; Yves Agid; Alexis Brice
Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations?
Brain : a journal of neurology 2000;123 ( Pt 6)():1112-21.
2000: Christoph B Lücking; Alexandra Dürr; Vincenzo Bonifati; J Vaughan; Giuseppe De Michele; Thomas Gasser; Biswadjiet S Harhangi; Giuseppe Meco; Patrice DENEFLE; Nicholas W Wood; Yves Agid; Alexis Brice
Association between early-onset Parkinson's disease and mutations in the parkin gene.
The New England journal of medicine 2000;342(21):1560-7.
2000: Boulos-Paul Bejjani; Isabelle Arnulf; Sophie Demeret; Philippe Damier; Anne-Marie Bonnet; Jean-Luc Houeto; Yves Agid
Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?
Annals of neurology 2000;47(5):655-8.
2000: Boulos-Paul Bejjani; D Gervais; Isabelle Arnulf; S Papadopoulos; Sophie Demeret; Anne-Marie Bonnet; Philippe Cornu; Philippe Damier; Yves Agid
Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation.
Journal of neurology, neurosurgery, and psychiatry 2000;68(5):595-600.
2000: Annick Mouatt-Prigent; J O Karlsson; Jérôme Yelnik; Yves Agid; Etienne C Hirsch
Calpastatin immunoreactivity in the monkey and human brain of control subjects and patients with Parkinson's disease.
The Journal of comparative neurology 2000;419(2):175-92.
2000: Tiziana Zalla; Angela Sirigu; Bernard Pillon; Bruno Dubois; Yves Agid; Jordan Grafman
How patients with Parkinson's disease retrieve and manage cognitive event knowledge.
Cortex; a journal devoted to the study of the nervous system and behavior 2000;36(2):163-79.
2000: Jean-Luc Houeto; Philippe Damier; Paul-Boulos Bejjani; C Staedler; Anne-Marie Bonnet; Isabelle Arnulf; Bernard Pidoux; Dominique Dormont; Philippe Cornu; Yves Agid
Subthalamic stimulation in Parkinson disease: a multidisciplinary approach.
Archives of neurology 2000;57(4):461-5.
2000: Boulos-Paul Bejjani; Dominique Dormont; Bernard Pidoux; Jérôme Yelnik; Philippe Damier; Isabelle Arnulf; Anne-Marie Bonnet; Claude Marsault; Yves Agid; Jacques Philippon; Philippe Cornu
Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance.
Journal of neurosurgery 2000;92(4):615-25.
2000: Wen-Jie Gu; Nacer Abbas; M Z Lagunes; A Parent; Laurent Pradier; Georg Andrees Bohme; Yves Agid; Etienne C Hirsch; Rita Raisman-Vozari; Alexis Brice
Cloning of rat parkin cDNA and distribution of parkin in rat brain.
Journal of neurochemistry 2000;74(4):1773-6.
2000: Andreas Hartmann; Stéphane Hunot; Patrick P Michel; Marie-Paule Muriel; Sheela Vyas; Baptiste A Faucheux; Annick Mouatt-Prigent; H Turmel; A Srinivasan; Merle Ruberg; Gerard I Evan; Yves Agid; Etienne C Hirsch
Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(6):2875-80.
2000: Isabelle Arnulf; Boulos-Paul Bejjani; L Garma; Anne-Marie Bonnet; Philippe Damier; Bernard Pidoux; Dominique Dormont; Philippe Cornu; Jean-Philippe Derenne; Yves Agid
Effect of low and high frequency thalamic stimulation on sleep in patients with Parkinson's disease and essential tremor.
Journal of sleep research 2000;9(1):55-62.
2000: Celine Perier; Miquel Vila; Jean Féger; Yves Agid; Etienne C Hirsch
Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats.
Experimental neurology 2000;162(1):215-24.
2000: D Brassat; Agnès Camuzat; Marie Vidailhet; I Feki; Pierre Jedynak; P Klap; Yves Agid; Alexandra Dürr; Alexis Brice
Frequency of the DYT1 mutation in primary torsion dystonia without family history.
Archives of neurology 2000;57(3):333-5.
2000: G Stevanin; A Herman; A Dürr; C Jodice; Marina Frontali; Yves Agid; Alexis Brice
Are (CTG)n expansions at the SCA8 locus rare polymorphisms?
Nature genetics 2000;24(3):213; author reply 215.
2000: Sophie Rivaud-Péchoux; AI Vermersch; Bertrand Gaymard; Christoph J Ploner; Boulos-Paul Bejjani; Philippe Damier; Sophie Demeret; Yves Agid; Charles Pierrot-Deseilligny
Improvement of memory guided saccades in parkinsonian patients by high frequency subthalamic nucleus stimulation.
Journal of neurology, neurosurgery, and psychiatry 2000;68(3):381-4.
2000: N Kubis; Baptiste A Faucheux; Gerhard Ransmayr; Philippe Damier; Charles Duyckaerts; D Henin; B Forette; Y Le Charpentier; JEAN-JACQUES HAUW; Yves Agid; Etienne C Hirsch
Preservation of midbrain catecholaminergic neurons in very old human subjects.
Brain : a journal of neurology 2000;123 ( Pt 2)():366-73.
2000: Jérôme Yelnik; Philippe Damier; Boulos-Paul Bejjani; C Francois; David Gervais; Dominique Dormont; Isabelle Arnulf; A M Bonnet; Philippe Cornu; Bernard Pidoux; Yves Agid
Functional mapping of the human globus pallidus: contrasting effect of stimulation in the internal and external pallidum in Parkinson's disease.
Neuroscience 2000;101(1):77-87.
2000: Gaël Orieux; C Francois; Jean Féger; Jérôme Yelnik; Miquel Vila; Merle Ruberg; Yves Agid; Etienne C Hirsch
Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease.
Neuroscience 2000;97(1):79-88.
2000: Yves Agid
[How to examine a patient with Parkinson disease].
Revue neurologique 2000;156(1):17-22.
2000: Miquel Vila; Celine Perier; Jean Féger; Jérôme Yelnik; Baptiste A Faucheux; Merle Ruberg; Rita Raisman-Vozari; Yves Agid; Etienne C Hirsch
Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements.
The European journal of neuroscience 2000;12(1):337-44.
2000: Yves Agid
Will neurological practice be different during the 21st century.
Archives of neurology 2000;57(1):56-7.
1999: S Crozier; Angela Sirigu; Stéphane Lehéricy; Pierre-Francois Van de Moortele; Bernard Pillon; Jordan Grafman; Yves Agid; Bruno Dubois; Denis LeBihan
Distinct prefrontal activations in processing sequence at the sentence and script level: an fMRI study.
Neuropsychologia 1999;37(13):1469-76.
1999: Giovanni Stevanin; G David; Alexandra Dürr; Paola Giunti; Ali Benomar; M Abada-Bendib; M S Lee; Yves Agid; Alexis Brice
Multiple origins of the spinocerebellar ataxia 7 (SCA7) mutation revealed by linkage disequilibrium studies with closely flanking markers, including an intragenic polymorphism (G3145TG/A3145TG).
European journal of human genetics : EJHG 1999;7(8):889-96.
1999: Chantal François; Jérôme Yelnik; Dominique Tandé; Yves Agid; Etienne C Hirsch
Dopaminergic cell group A8 in the monkey: anatomical organization and projections to the striatum.
The Journal of comparative neurology 1999;414(3):334-47.
1999: Yves Agid
Continuous high frequency stimulation of deep brain structures in brain pathology.
Brain research bulletin 1999;50(5-6):475.
1999: Yves Agid; E Ahlskog; A Albanese; Donald B Calne; Thomas N Chase; J De Yebenes; Stewart A Factor; Stanley Fahn; Oscar S Gershanik; Christopher G Goetz; William Koller; M Kurth; Anthony E Lang; Andrew J Lees; Peter LeWitt; D Marsden; Eldad Melamed; Patrick P Michel; Yoshikuni Mizuno; Jose A Obeso; Wolfgang H Oertel; W Olanow; Werner Poewe; Pierre Pollak; Eduardo Tolosa
Levodopa in the treatment of Parkinson's disease: a consensus meeting.
Movement disorders : official journal of the Movement Disorder Society 1999;14(6):911-3.
1999: Jérôme N Huillard d'Aignaux; Dominique Costagliola; Jean Maccario; T Billette de Villemeur; Jean-Philippe Brandel; Jean-Philippe Deslys; JEAN-JACQUES HAUW; J L Chaussain; Yves Agid; D Dormont; Annick Alpérovitch
Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France.
Neurology 1999;53(6):1197-201.
1999: D Brassat; A Durr; Yves Agid; Alexis Brice
[Genetics of Parkinson disease].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1999;20(8):709-14.
1999: Yves Agid
Parkinson's disease or Parkinson's diseases?
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1999;53(7):301-2.
1999: Marie Vidailhet; C Dupel; Stéphane Lehéricy; P Remy; D Dormont; M Serdaru; Pierre Jedynak; H Veber; Y Samson; Claude Marsault; Yves Agid
Dopaminergic dysfunction in midbrain dystonia: anatomoclinical study using 3-dimensional magnetic resonance imaging and fluorodopa F 18 positron emission tomography.
Archives of neurology 1999;56(8):982-9.
1999: Christoph J Ploner; Sophie Rivaud-Péchoux; Bertrand Gaymard; Yves Agid; Charles Pierrot-Deseilligny
Errors of memory-guided saccades in humans with lesions of the frontal eye field and the dorsolateral prefrontal cortex.
Journal of neurophysiology 1999;82(2):1086-90.
1999: Claire Ardouin; Bernard Pillon; E Peiffer; Paul-Boulos Bejjani; Patricia Limousin; Philippe Damier; Isabelle Arnulf; Alim-Louis Benabid; Yves Agid; Pierre Pollak
Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients.
Annals of neurology 1999;46(2):217-23.
1999: Philippe Damier; Etienne C Hirsch; Yves Agid; Ann M Graybiel
The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.
Brain : a journal of neurology 1999;122 ( Pt 8)():1437-48.
1999: Philippe Damier; Etienne C Hirsch; Yves Agid; Ann M Graybiel
The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry.
Brain : a journal of neurology 1999;122 ( Pt 8)():1421-36.
1999: Yves Agid; F Lhermitte
Facilitory paratonia and frontal lobe functioning.
Neurology 1999;53(1):241.
1999: Marc-André Bédard; B Pillon; Bruno Dubois; N Duchesne; Hélène Masson; Yves Agid
Acute and long-term administration of anticholinergics in Parkinson's disease: specific effects on the subcortico-frontal syndrome.
Brain and cognition 1999;40(2):289-313.
1999: Marie-Paule Muriel; Véronique Bernard; Allan Levey; O Laribi; Djoher Nora Abrous; Yves Agid; Bertrand Bloch; Etienne C Hirsch
Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease.
Annals of neurology 1999;46(1):103-11.
1999: Miquel Vila; Concepció Marin; Merle Ruberg; Anna Jimenez; Rita Raisman-Vozari; Yves Agid; Eduardo Tolosa; Etienne C Hirsch
Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia.
Journal of neurochemistry 1999;73(1):344-52.
1999: Boulos-Paul Bejjani; Philippe Damier; Isabelle Arnulf; Lionel Thivard; Anne-Marie Bonnet; Dominique Dormont; Philippe Cornu; Bernard Pidoux; Yves Samson; Yves Agid
Transient acute depression induced by high-frequency deep-brain stimulation.
The New England journal of medicine 1999;340(19):1476-80.
1999: Patrick P Michel; Marc Marien; Merle Ruberg; Francis Colpaert; Yves Agid
Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes.
Journal of neurochemistry 1999;72(5):2074-82.
1999: Stéphane Hunot; Nathalie Dugas; Baptiste A Faucheux; Andreas Hartmann; M Tardieu; Patrice Debré; Yves Agid; Bernard Dugas; Etienne C Hirsch
FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1999;19(9):3440-7.
1999: AI Vermersch; Bertrand Gaymard; Sophie Rivaud-Pechoux; Christoph J Ploner; Yves Agid; Charles Pierrot-Deseilligny
Memory guided saccade deficit after caudate nucleus lesion.
Journal of neurology, neurosurgery, and psychiatry 1999;66(4):524-7.
1999: Nacer Abbas; Christoph B Lücking; Sylvain Ricard; Alexandra Dürr; Vincenzo Bonifati; Giuseppe De Michele; S Bouley; Jenny R Vaughan; Thomas Gasser; Roberto Marconi; Emmanuel Broussolle; C Brefel-Courbon; Biswadjiet S Harhangi; Ben A Oostra; Edito Fabrizio; G A Böhme; Laurent Pradier; Nicholas W Wood; Alessandro Filla; Giuseppe Meco; Patrice DENEFLE; Yves Agid; Alexis Brice
A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.
Human molecular genetics 1999;8(4):567-74.
1999: Etienne C Hirsch; L J Hu; A Prigent; Bruno Constantin; Yves Agid; Harry A Drabkin; Joelle Roche
Distribution of semaphorin IV in adult human brain.
Brain research 1999;823(1-2):67-79.
1999: B A Faucheux; Anne-Marie Bonnet; Yves Agid; Etienne C Hirsch
Blood vessels change in the mesencephalon of patients with Parkinson's disease.
Lancet 1999;353(9157):981-2.
1999: M Gustavo Murer; Rita Raisman-Vozari; Q Yan; Merle Ruberg; Yves Agid; Patrick P Michel
Survival factors promote BDNF protein expression in mesencephalic dopaminergic neurons.
Neuroreport 1999;10(4):801-5.
1999: M Rösler; R Anand; A Cicin-Sain; S Gauthier; Yves Agid; P Dal-Bianco; H B Stähelin; R Hartman; M Gharabawi
Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial.
BMJ (Clinical research ed.) 1999;318(7184):633-8.
1999: Nathalie Lambeng; Patrick P Michel; Bernard Brugg; Yves Agid; Merle Ruberg
Mechanisms of apoptosis in PC12 cells irreversibly differentiated with nerve growth factor and cyclic AMP.
Brain research 1999;821(1):60-8.
1999: Etienne C Hirsch; Stéphane Hunot; Baptiste A Faucheux; Yves Agid; Yoshikuni Mizuno; H Mochizuki; William G Tatton; Nadine A Tatton; W C Olanow
Dopaminergic neurons degenerate by apoptosis in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1999;14(2):383-5.
1999: Franck Durif; M Vidailhet; Bérengère Debilly; Yves Agid
Worsening of levodopa-induced dyskinesias by motor and mental tasks.
Movement disorders : official journal of the Movement Disorder Society 1999;14(2):242-5.
1999: N Sabbagh; Alexis Brice; D Marez; A Dürr; M Legrand; Jean-Marc Lo-Guidice; Alain Destée; Yves Agid; Franck Broly
CYP2D6 polymorphism and Parkinson's disease susceptibility.
Movement disorders : official journal of the Movement Disorder Society 1999;14(2):230-6.
1999: Karine Parain; M Gustavo Murer; Q Yan; Baptiste A Faucheux; Yves Agid; Etienne C Hirsch; Rita Raisman-Vozari
Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra.
Neuroreport 1999;10(3):557-61.
1999: E Růzicka; F el Massioui; B Pillon; Bruno Dubois; B Renault; Yves Agid
The effects of apomorphine on attentional processing in Parkinson's disease.
Sborník lékar̆ský 1999;100(2):85-99.
1999: Philippe Damier; C Jaillon; I Clavier; Isabelle Arnulf; Anne-Marie Bonnet; B P Bejjani; Yves Agid
Dyskinesias assessment in Phase II studies.
Movement disorders : official journal of the Movement Disorder Society 1999;14 Suppl 1():54-9.
1999: Marie Vidailhet; Anne-Marie Bonnet; R Marconi; Franck Durif; Yves Agid
The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1999;14 Suppl 1():13-8.
1999: Marie Vidailhet; Sophie Rivaud; N Gouider-Khouja; Bernard Pillon; Bertrand Gaymard; Yves Agid; C Kennard; Charles Pierrot-Deseilligny
Saccades and antisaccades in parkinsonian syndromes.
Advances in neurology 1999;80():377-82.
1999: Etienne C Hirsch; Stéphane Hunot; Philippe Damier; Bernard Brugg; Baptiste A Faucheux; Patrick P Michel; Merle Ruberg; Marie-Paule Muriel; Annick Mouatt-Prigent; Yves Agid
Glial cell participation in the degeneration of dopaminergic neurons in Parkinson's disease.
Advances in neurology 1999;80():9-18.
1999: M Gustavo Murer; F Boissiere; Q Yan; Stéphane Hunot; J Villares; Baptiste A Faucheux; Yves Agid; Etienne C Hirsch; Rita Raisman-Vozari
An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease.
Neuroscience 1999;88(4):1015-32.
1999: Anne-Sophie Lebre; Alexandra Durr; Pierre Jedynak; Gérard Ponsot; Marie Vidailhet; Yves Agid; Alexis Brice
DYT1 mutation in French families with idiopathic torsion dystonia.
Brain : a journal of neurology 1999;122 ( Pt 1)():41-5.
1998: Angela Sirigu; laurent cohen; Tiziana Zalla; Pascale Pradat-Diehl; P Van Eeckhout; Jordan Grafman; Yves Agid
Distinct frontal regions for processing sentence syntax and story grammar.
Cortex; a journal devoted to the study of the nervous system and behavior 1998;34(5):771-8.
1998: F Picard; J Tassin; M Vidailhet; C Marescaux; F Picard; Yves Agid; Alexis Brice
Autosomal dominant paroxysmal kinesigenic choreoathetosis: a clinical and genetic study of two families.
Journal of neurology, neurosurgery, and psychiatry 1998;65(6):955-6.
1998: J Villares; Baptiste A Faucheux; María-Trinidad Herrero; Jose A Obeso; Charles Duyckaerts; JEAN-JACQUES HAUW; Yves Agid; Etienne C Hirsch
[125I]EGF binding in basal ganglia of patients with Parkinson's disease and progressive supranuclear palsy and in MPTP-treated monkeys.
Experimental neurology 1998;154(1):146-56.
1998: Boulos-Paul Bejjani; Philippe Damier; Isabelle Arnulf; S Papadopoulos; Anne-Marie Bonnet; Marie Vidailhet; Yves Agid; Bernard Pidoux; Philippe Cornu; Dominique Dormont; Claude Marsault
Deep brain stimulation in Parkinson's disease: opposite effects of stimulation in the pallidum.
Movement disorders : official journal of the Movement Disorder Society 1998;13(6):969-70.
1998: Christoph B Lücking; Nacer Abbas; Alexandra Dürr; Vincenzo Bonifati; Anne-Marie Bonnet; T de Broucker; G De Michele; Nicholas W Wood; Yves Agid; Alexis Brice
Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism. The European Consortium on Genetic Susceptibility in Parkinson's Disease and the French Parkinson's Disease Genetics Study Group.
Lancet 1998;352(9137):1355-6.
1998: J P Brandel; Yves Agid
[Creutzfeldt-Jakob disease after treatment with growth hormone: the point in July, 1998].
Revue neurologique 1998;154(10):654-5.
1998: Cécile Dumanchin; Agnès Camuzat; Dominique Campion; Patrice Verpillat; D Hannequin; Bruno Dubois; Pascale Saugier-Veber; Cosette Martin; C Penet; Frédéric Charbonnier; Yves Agid; Thierry Frebourg; Alexis Brice
Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism.
Human molecular genetics 1998;7(11):1825-9.
1998: S Benisty; F Boissiere; Baptiste A Faucheux; Yves Agid; Etienne C Hirsch
trkB messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients: an in situ hybridization study.
Neuroscience 1998;86(3):813-26.
1998: Tiziana Zalla; Angela Sirigu; Bernard Pillon; Bruno Dubois; Jordan Grafman; Yves Agid
Deficit in evaluating pre-determined sequences of script events in patients with Parkinson's disease.
Cortex; a journal devoted to the study of the nervous system and behavior 1998;34(4):621-7.
1998: Stéphane Lehéricy; Pierre-Francois Van de Moortele; Elie Lobel; Anne-Lise Paradis; M Vidailhet; V Frouin; P Neveu; Yves Agid; Claude Marsault; Denis Le Bihan
Somatotopical organization of striatal activation during finger and toe movement: a 3-T functional magnetic resonance imaging study.
Annals of neurology 1998;44(3):398-404.
1998: Cécile Dumanchin; Alexis Brice; Dominique Campion; Didier Hannequin; Cosette Martin; V Moreau; Yves Agid; M Martinez; Françoise Clerget-Darpoux; Thierry Frebourg
De novo presenilin 1 mutations are rare in clinically sporadic, early onset Alzheimer's disease cases. French Alzheimer's Disease Study Group.
Journal of medical genetics 1998;35(8):672-3.
1998: J Vaughan; Alexandra Durr; JP Tassin; Benjamin Bereznai; Thomas Gasser; Vincenzo Bonifati; Giuseppe De Michele; Edito Fabrizio; Giampiero Volpe; O Bandmann; William G Johnson; Lawrence I Golbe; Monique Breteler; Giuseppe Meco; Yves Agid; Alexis Brice; CD Marsden; Nicholas W Wood
The alpha-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: a study of 230 European cases. European Consortium on Genetic Susceptibility in Parkinson's Disease.
Annals of neurology 1998;44(2):270-3.
1998: F Boissière; Baptiste A Faucheux; Charles Duyckaerts; JEAN-JACQUES HAUW; Yves Agid; Etienne C Hirsch
Striatal expression of glutamic acid decarboxylase gene in Alzheimer's disease.
Journal of neurochemistry 1998;71(2):767-74.
1998: I Litvan; A MacIntyre; Christopher G Goetz; Gregor Wenning; Kurt A Jellinger; M Verny; John J Bartko; Joseph Jankovic; A McKee; Jean-Philippe Brandel; K Ray Chaudhuri; EC Lai; L D'Olhaberriague; RK Pearce; Yves Agid
Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study.
Archives of neurology 1998;55(7):969-78.
1998: JP Tassin; Alexandra Dürr; T de Broucker; Nacer Abbas; Vincenzo Bonifati; Giuseppe De Michele; Anne-Marie Bonnet; Emmanuel Broussolle; Pierre Pollak; Marie Vidailhet; Michele De Mari; Roberto Marconi; S Medjbeur; Alessandro Filla; Giuseppe Meco; Yves Agid; Alexis Brice
Chromosome 6-linked autosomal recessive early-onset Parkinsonism: linkage in European and Algerian families, extension of the clinical spectrum, and evidence of a small homozygous deletion in one family. The French Parkinson's Disease Genetics Study Group, and the European Consortium on Genetic Susceptibility in Parkinson's Disease.
American journal of human genetics 1998;63(1):88-94.
1998: Isabelle Gourfinkel-An; G Cancel; Charles Duyckaerts; Baptiste A Faucheux; JEAN-JACQUES HAUW; Yvon Trottier; Alexis Brice; Yves Agid; Etienne C Hirsch
Neuronal distribution of intranuclear inclusions in Huntington's disease with adult onset.
Neuroreport 1998;9(8):1823-6.
1998: M Martinez; Dominique Campion; Alexis Brice; Didier Hannequin; Bruno Dubois; O Didierjean; A Michon; Catherine Thomas-Anterion; Michèle Puel; Thierry Frebourg; Yves Agid; Françoise Clerget-Darpoux
Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease.
Archives of neurology 1998;55(6):810-6.
1998: Bertrand Gaymard; Sophie Rivaud; J F Cassarini; T Dubard; Gérald Rancurel; Yves Agid; Charles Pierrot-Deseilligny
Effects of anterior cingulate cortex lesions on ocular saccades in humans.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1998;120(2):173-83.
1998: M Gustavo Murer; G Dziewczapolski; LB Menalled; M C García; Yves Agid; Oscar S Gershanik; Rita Raisman-Vozari
Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
Annals of neurology 1998;43(5):561-75.
1998: M Holmberg; Charles Duyckaerts; Alexandra Dürr; G Cancel; Isabelle Gourfinkel-An; Philippe Damier; Baptiste A Faucheux; Yvon Trottier; Etienne C Hirsch; Yves Agid; Alexis Brice
Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions.
Human molecular genetics 1998;7(5):913-8.
1998: G Ballan; François Tison; V Dousset; M Vidailhet; Yves Agid; P Henry
[Study of cortical atrophy with magnetic resonance imaging in corticobasal degeneration].
Revue neurologique 1998;154(3):224-7.
1998: Nazha Birouk; Eric LeGuern; Thierry Maisonobe; H Rouger; Riadh Gouider; Sandrine Tardieu; M Gugenheim; MC Routon; Jean-Marc Léger; Yves Agid; Alexis Brice; Pierre Bouche
X-linked Charcot-Marie-Tooth disease with connexin 32 mutations: clinical and electrophysiologic study.
Neurology 1998;50(4):1074-82.
1998: Yves Agid
Levodopa: is toxicity a myth?
Neurology 1998;50(4):858-63.
1998: Jenny R Vaughan; Matthew J Farrer; Zbigniew K Wszolek; Thomas Gasser; Alexandra Durr; Yves Agid; Vincenzo Bonifati; G DeMichele; Giampiero Volpe; Sarah J Lincoln; Monique Breteler; Giuseppe Meco; Alexis Brice; CD Marsden; John Hardy; Nicholas W Wood
Sequencing of the alpha-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations. The European Consortium on Genetic Susceptibility in Parkinson's Disease (GSPD).
Human molecular genetics 1998;7(4):751-3.
1998: Yves Agid; Thomas N Chase; D Marsden
Adverse reactions to levodopa: drug toxicity or progression of disease?
Lancet 1998;351(9106):851-2.
1998: Marc-André Bédard; F el Massioui; Chara Malapani; Bruno Dubois; Bernard Pillon; Bernard Renault; Yves Agid
Attentional deficits in Parkinson's disease: partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic alpha 1 agonist.
Clinical neuropharmacology 1998;21(2):108-17.
1998: Sophie Rivaud-Pechoux; Alexandra Dürr; Bertrand Gaymard; G Cancel; Christoph J Ploner; Yves Agid; Alexis Brice; Charles Pierrot-Deseilligny
Eye movement abnormalities correlate with genotype in autosomal dominant cerebellar ataxia type I.
Annals of neurology 1998;43(3):297-302.
1998: Christoph J Ploner; Bertrand Gaymard; Sophie Rivaud; Yves Agid; Charles Pierrot-Deseilligny
Temporal limits of spatial working memory in humans.
The European journal of neuroscience 1998;10(2):794-7.
1998: C T Ferreira; M Vérin; Bernard Pillon; R Levy; Bruno Dubois; Yves Agid
Spatio-temporal working memory and frontal lesions in man.
Cortex; a journal devoted to the study of the nervous system and behavior 1998;34(1):83-98.
1998: Valerie Hahn-Barma; Bernard Deweer; Alexandra Dürr; Catherine Dodé; JOSUE FEINGOLD; Bernard Pillon; Yves Agid; Alexis Brice; Bruno Dubois
Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers.
Journal of neurology, neurosurgery, and psychiatry 1998;64(2):172-7.
1998: S Pol; Marie Vidailhet; Sabine Meunier; Dominique Mazevet; Yves Agid; emmanuel pierrot-deseilligny
Overactivity of cervical premotor neurons in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1998;64(2):166-71.
1998: G David; Alexandra Dürr; Giovanni Stevanin; G Cancel; Nacer Abbas; Ali Benomar; Samir Belal; Anne-Sophie Lebre; M Abada-Bendib; Djamel Grid; M Holmberg; Mohamed Yahyaoui; Faycal Hentati; Taïeb Chkili; Yves Agid; Alexis Brice
Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7).
Human molecular genetics 1998;7(2):165-70.
1998: Didier Hannequin; Dominique Campion; Cécile Dumanchin; M Martinez; Yves Agid; Françoise Clerget-Darpoux; Thierry Frebourg; Alexis Brice
[Genetics of Alzheimer's disease].
Revue neurologique 1998;154 Suppl 2():S65-74.
1998: Marie Vidailhet; CP Jedynak; Pierre Pollak; Yves Agid
Pathology of symptomatic tremors.
Movement disorders : official journal of the Movement Disorder Society 1998;13 Suppl 3():49-54.
1998: M Vidailhet; Anne-Marie Bonnet; Yves Agid
[Clinical diagnostic criteria for multiple system atrophy].
Revue neurologique 1998;154(1):17-21.
1998: I Litvan; VJ Booth; Gregor Wenning; John J Bartko; Christopher G Goetz; A McKee; Joseph Jankovic; Kurt A Jellinger; EC Lai; Jean-Philippe Brandel; M Verny; K Ray Chaudhuri; RK Pearce; Yves Agid
Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy.
Journal of neural transmission (Vienna, Austria : 1996) 1998;105(2-3):217-27.
1998: G Cancel; Isabelle Gourfinkel-An; Giovanni Stevanin; O Didierjean; Nacer Abbas; Etienne C Hirsch; Yves Agid; Alexis Brice
Somatic mosaicism of the CAG repeat expansion in spinocerebellar ataxia type 3/Machado-Joseph disease.
Human mutation 1998;11(1):23-7.
1997: Boulos-Paul Bejjani; Philippe Damier; Isabelle Arnulf; Anne-Marie Bonnet; Marie Vidailhet; Dominique Dormont; Bernard Pidoux; Philippe Cornu; Claude Marsault; Yves Agid
Pallidal stimulation for Parkinson's disease. Two targets?
Neurology 1997;49(6):1564-9.
1997: Isabelle Gourfinkel-An; G Cancel; Yvon Trottier; Didier Devys; Làszlò Tora; Yves Lutz; G Imbert; Frédéric Saudou; Giovanni Stevanin; Yves Agid; Alexis Brice; Jean-Louis Mandel; Etienne C Hirsch
Differential distribution of the normal and mutated forms of huntingtin in the human brain.
Annals of neurology 1997;42(5):712-9.
1997: Giovanni Stevanin; Alexandra Dürr; G David; O Didierjean; G Cancel; Sophie Rivaud; Ayman Tourbah; J M Warter; Yves Agid; Alexis Brice
Clinical and molecular features of spinocerebellar ataxia type 6.
Neurology 1997;49(5):1243-6.
1997: V France-Lanord; Bernard Brugg; Patrick P Michel; Yves Agid; Merle Ruberg
Mitochondrial free radical signal in ceramide-dependent apoptosis: a putative mechanism for neuronal death in Parkinson's disease.
Journal of neurochemistry 1997;69(4):1612-21.
1997: Patrick P Michel; Merle Ruberg; Yves Agid
Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside.
Journal of neurochemistry 1997;69(4):1499-507.
1997: F Boissière; Stéphane Hunot; Baptiste A Faucheux; Charles Duyckaerts; JEAN-JACQUES HAUW; Yves Agid; Etienne C Hirsch
Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer's disease.
Neuroreport 1997;8(13):2849-52.
1997: Yves Agid; Alain Destée; Franck Durif; Jean-Louis Montastruc; Pierre Pollak
Tolcapone, bromocriptine, and Parkinson's disease. French Tolcapone Study Group.
Lancet 1997;350(9079):712-3.
1997: Merle Ruberg; V France-Lanord; Bernard Brugg; Nathalie Lambeng; Patrick P Michel; P Anglade; Stéphane Hunot; Philippe Damier; Baptiste A Faucheux; Etienne C Hirsch; Yves Agid
[Neuronal death caused by apoptosis in Parkinson disease].
Revue neurologique 1997;153(8-9):499-508.
1997: G David; Nacer Abbas; Giovanni Stevanin; Alexandra Dürr; Gaël Yvert; G Cancel; C Weber; G Imbert; Frédéric Saudou; E Antoniou; Harry A Drabkin; Robert M Gemmill; Paola Giunti; Ali Benomar; Nicholas W Wood; Merle Ruberg; Yves Agid; Jean-Louis Mandel; Alexis Brice
Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion.
Nature genetics 1997;17(1):65-70.
1997: G Murer; C Adelbrecht; Inger Lauritzen; Florian Lesage; Michel Lazdunski; Yves Agid; Rita Raisman-Vozari
An immunocytochemical study on the distribution of two G-protein-gated inward rectifier potassium channels (GIRK2 and GIRK4) in the adult rat brain.
Neuroscience 1997;80(2):345-57.
1997: I Litvan; Christopher G Goetz; Joseph Jankovic; Gregor Wenning; VJ Booth; John J Bartko; A McKee; Kurt A Jellinger; EC Lai; Jean-Philippe Brandel; M Verny; K Ray Chaudhuri; RK Pearce; Yves Agid
What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study.
Archives of neurology 1997;54(8):937-44.
1997: Thomas Gasser; Bertram Müller-Myhsok; Zbigniew K Wszolek; Alexandra Dürr; Jenny R Vaughan; Vincenzo Bonifati; Giuseppe Meco; Benjamin Bereznai; R Oehlmann; Yves Agid; Alexis Brice; Nicholas W Wood
Genetic complexity and Parkinson's disease.
Science (New York, N.Y.) 1997;277(5324):388-9; author reply 389.
1997: Stéphane Hunot; Bernard Brugg; Damien Ricard; Patrick P Michel; Marie-Paule Muriel; Merle Ruberg; Baptiste A Faucheux; Yves Agid; Etienne C Hirsch
Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(14):7531-6.
1997: Anne-Marie Bonnet; J Pichon; Marie Vidailhet; N Gouider-Khouja; Gilberte Robain; Michel Perrigot; Yves Agid
Urinary disturbances in striatonigral degeneration and Parkinson's disease: clinical and urodynamic aspects.
Movement disorders : official journal of the Movement Disorder Society 1997;12(4):509-13.
1997: P Anglade; Sheela Vyas; Etienne C Hirsch; Yves Agid
Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging.
Histology and histopathology 1997;12(3):603-10.
1997: I Litvan; Yves Agid; N Sastry; Joseph Jankovic; Gregor Wenning; Christopher G Goetz; M Verny; Jean-Philippe Brandel; Kurt A Jellinger; K Ray Chaudhuri; A McKee; EC Lai; RK Pearce; John J Bartko; N Sastrj
What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study.
Neurology 1997;49(1):62-9.
1997: O Didierjean; M Martinez; Dominique Campion; Didier Hannequin; Bruno Dubois; Cosette Martin; Michèle Puel; Catherine Thomas-Anterion; Florence Pasquier; O Moreau; Marie-Claude Babron; C Penet; Yves Agid; Françoise Clerget-Darpoux; Thierry Frebourg; Alexis Brice
No effect of the alpha1-antichymotrypsin A allele in Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 1997;63(1):103-5.
1997: Sheela Vyas; France Javoy-Agid; María-Trinidad Herrero; O Strada; F Boissiere; U Hibner; Yves Agid
Expression of Bcl-2 in adult human brain regions with special reference to neurodegenerative disorders.
Journal of neurochemistry 1997;69(1):223-31.
1997: Giovanni Stevanin; Anne-Sophie Lebre; C Mathieux; G Cancel; Nacer Abbas; O Didierjean; Alexandra Dürr; Yvon Trottier; Yves Agid; Alexis Brice
Linkage disequilibrium between the spinocerebellar ataxia 3/Machado-Joseph disease mutation and two intragenic polymorphisms, one of which, X359Y, affects the stop codon.
American journal of human genetics 1997;60(6):1548-52.
1997: D Dormont; Philippe Cornu; Bernard Pidoux; Anne-Marie Bonnet; Alessandra Biondi; Catherine Oppenheim; Dominique Hasboun; Philippe Damier; E Cuchet; Jacques Philippon; Yves Agid; Claude Marsault
Chronic thalamic stimulation with three-dimensional MR stereotactic guidance.
AJNR. American journal of neuroradiology 1997;18(6):1093-107.
1997: F Boissiere; Baptiste A Faucheux; Merle Ruberg; Yves Agid; Etienne C Hirsch
Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease.
Experimental neurology 1997;145(1):245-52.
1997: Nazha Birouk; Riadh Gouider; Eric Le Guern; M Gugenheim; Sandrine Tardieu; Thierry Maisonobe; Nadine Le Forestier; Yves Agid; Alexis Brice; Pierre Bouche
Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases.
Brain : a journal of neurology 1997;120 ( Pt 5)():813-23.
1997: G Cancel; Alexandra Dürr; O Didierjean; G Imbert; Katrin Bürk; Agnes Lezin; Samir Belal; Ali Benomar; M Abada-Bendib; C Vial; J Guimarães; H Chneiweiss; Giovanni Stevanin; Gaël Yvert; Nacer Abbas; Frédéric Saudou; Anne-Sophie Lebre; Mohamed Yahyaoui; Faycal Hentati; JC Vernant; Thomas Klockgether; Jean-Louis Mandel; Yves Agid; Alexis Brice
Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families.
Human molecular genetics 1997;6(5):709-15.
1997: Merle Ruberg; Bernard Brugg; A Prigent; Etienne C Hirsch; Alexis Brice; Yves Agid
Is differential regulation of mitochondrial transcripts in Parkinson's disease related to apoptosis?
Journal of neurochemistry 1997;68(5):2098-110.
1997: F Boissière; Baptiste A Faucheux; Yves Agid; Etienne C Hirsch
Choline acetyltransferase mRNA expression in the striatal neurons of patients with Alzheimer's disease.
Neuroscience letters 1997;225(3):169-72.
1997: G Dziewczapolski; G Murer; Yves Agid; Oscar S Gershanik; Rita Raisman-Vozari
Absence of neurotoxicity of chronic L-DOPA in 6-hydroxydopamine-lesioned rats.
Neuroreport 1997;8(4):975-9.
1997: C Adelbrecht; M Gustavo Murer; Inger Lauritzen; Florian Lesage; M Ladzunski; Yves Agid; Rita Raisman-Vozari
An immunocytochemical study of a G-protein-gated inward rectifier K+ channel (GIRK2) in the weaver mouse mesencephalon.
Neuroreport 1997;8(4):969-74.
1997: Franck Durif; M Vidailhet; F Assal; C Roche; Anne-Marie Bonnet; Yves Agid
Low-dose clozapine improves dyskinesias in Parkinson's disease.
Neurology 1997;48(3):658-62.
1997: Baptiste A Faucheux; JEAN-JACQUES HAUW; Yves Agid; Etienne C Hirsch
The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease.
Brain research 1997;749(1):170-4.
1997: H Bickeböller; Dominique Campion; Alexis Brice; Philippe Amouyel; Didier Hannequin; O Didierjean; C Penet; Cosette Martin; Jordi Pérez-Tur; A Michon; Bruno Dubois; F Ledoze; Catherine Thomas-Anterion; Florence Pasquier; Michèle Puel; Jean-Francois Demonet; Olivier Moreaud; Marie-Claude Babron; D Meulien; D Guez; Marie-Christine Chartier-Harlin; Thierry Frebourg; Yves Agid; M Martinez; Françoise Clerget-Darpoux
Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex.
American journal of human genetics 1997;60(2):439-46.
1997: F Boissière; Baptiste A Faucheux; Yves Agid; Etienne C Hirsch
Expression of catalytic trkB gene in the striatum and the basal forebrain of patients with Alzheimer's disease: an in situ hybridization study.
Neuroscience letters 1997;221(2-3):141-4.
1997: Miquel Vila; R Levy; María-Trinidad Herrero; Merle Ruberg; Baptiste A Faucheux; Jose A Obeso; Yves Agid; Etienne C Hirsch
Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1997;17(2):765-73.
1997: H Rouger; Eric LeGuern; Nazha Birouk; Riadh Gouider; Sandrine Tardieu; Emmanuelle Plassart-Schiess; M Gugenheim; Jean-Michel Vallat; Jean-Pierre Louboutin; Pierre Bouche; Yves Agid; Alexis Brice
Charcot-Marie-Tooth disease with intermediate motor nerve conduction velocities: characterization of 14 Cx32 mutations in 35 families.
Human mutation 1997;10(6):443-52.
1997: Etienne C Hirsch; Baptiste A Faucheux; Philippe Damier; Annick Mouatt-Prigent; Yves Agid
Neuronal vulnerability in Parkinson's disease.
Journal of neural transmission. Supplementum 1997;50():79-88.
1997: P Anglade; Sheela Vyas; France Javoy-Agid; María-Trinidad Herrero; Patrick P Michel; J Marquez; Annick Mouatt-Prigent; Merle Ruberg; Etienne C Hirsch; Yves Agid
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
Histology and histopathology 1997;12(1):25-31.
1997: R Levy; L N Hazrati; María-Trinidad Herrero; Miquel Vila; OK Hassani; Mireille Mouroux; Merle Ruberg; H Asensi; Yves Agid; Jean Féger; Jose A Obeso; A Parent; Etienne C Hirsch
Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states.
Neuroscience 1997;76(2):335-43.
1997: I Litvan; Yves Agid; Christopher G Goetz; Joseph Jankovic; Gregor Wenning; Jean-Philippe Brandel; EC Lai; M Verny; K Ray-Chaudhuri; A McKee; Kurt A Jellinger; RK Pearce; John J Bartko
Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study.
Neurology 1997;48(1):119-25.
1997: F Boissière; Stéphane Hunot; Baptiste A Faucheux; Louis B Hersh; Yves Agid; Etienne C Hirsch
Trk neurotrophin receptors in cholinergic neurons of patients with Alzheimer's disease.
Dementia and geriatric cognitive disorders 1997;8(1):1-8.
1996: C Adelbrecht; Yves Agid; Rita Raisman-Vozari
Effect of the weaver mutation on the expression of dopamine membrane transporter, tyrosine hydroxylase and vesicular monoamine transporter in dopaminergic neurons of the substantia nigra and the ventral tegmental area.
Brain research. Molecular brain research 1996;43(1-2):291-300.
1996: Alexis Brice; Bruno Dubois; Yves Agid; Dominique Campion; M Martinez; F Clerger-Darpoux; M Bellis; J Mallet; Thierry Frebourg; Didier Hannequin; Michèle Puel; F Ledoze; Florence Pasquier; M A Zimmerman; Catherine Thomas-Anterion; O Moreaud; J Y Goas
[Genetics of dominant autosomal forms of Alzheimer disease: 3 genes and one phenotype. Groupe de Recherche Francais sur la Maladie d'Alzheimer].
Revue neurologique 1996;152(12):725-6.
1996: Gianni Pezzoli; O Strada; Vincenzo Silani; A Zecchinelli; Luigi Perbellini; France Javoy-Agid; P Ghidoni; E D Motti; T Masini; Guglielmo Scarlato; Yves Agid; Etienne C Hirsch
Clinical and pathological features in hydrocarbon-induced parkinsonism.
Annals of neurology 1996;40(6):922-5.
1996: M Chritin; V Blanchard; Rita Raisman-Vozari; Claude Feuerstein; Yves Agid; France Javoy-Agid; M Savasta
DA uptake sites, D1 and D2 receptors, D2 and preproenkephalin mRNAs and Fos immunoreactivity in rat striatal subregions after partial dopaminergic degeneration.
The European journal of neuroscience 1996;8(12):2511-20.
1996: Giovanni Stevanin; Yvon Trottier; G Cancel; Alexandra Dürr; G David; O Didierjean; Katrin Bürk; G Imbert; Frédéric Saudou; M Abada-Bendib; Isabelle Gourfinkel-An; Ali Benomar; Nacer Abbas; Thomas Klockgether; Djamel Grid; Yves Agid; Jean-Louis Mandel; Alexis Brice
Screening for proteins with polyglutamine expansions in autosomal dominant cerebellar ataxias.
Human molecular genetics 1996;5(12):1887-92.
1996: G David; Paola Giunti; Nacer Abbas; Philippe Coullin; Giovanni Stevanin; W Horta; Robert M Gemmill; Jean Weissenbach; Nicholas W Wood; S Cunha; Harry A Drabkin; A E Harding; Yves Agid; Alexis Brice
The gene for autosomal dominant cerebellar ataxia type II is located in a 5-cM region in 3p12-p13: genetic and physical mapping of the SCA7 locus.
American journal of human genetics 1996;59(6):1328-36.
1996: María-Trinidad Herrero; S J Augood; H Asensi; Etienne C Hirsch; Yves Agid; Jose A Obeso; P C Emson
Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys.
Brain research. Molecular brain research 1996;42(1):149-55.
1996: G Imbert; Frédéric Saudou; Gaël Yvert; Didier Devys; Yvon Trottier; J M Garnier; C Weber; Jean-Louis Mandel; G Cancel; Nacer Abbas; Alexandra Dürr; O Didierjean; Giovanni Stevanin; Yves Agid; Alexis Brice
Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats.
Nature genetics 1996;14(3):285-91.
1996: Alexandra Dürr; M Cossee; Yves Agid; V Campuzano; C Mignard; C Penet; Jean-Louis Mandel; Alexis Brice; Michel Koenig
Clinical and genetic abnormalities in patients with Friedreich's ataxia.
The New England journal of medicine 1996;335(16):1169-75.
1996: J Guridi; María-Trinidad Herrero; Maria Rosario Luquin; Javier Guillén; Merle Ruberg; J Laguna; Miquel Vila; France Javoy-Agid; Yves Agid; Etienne C Hirsch; Jose A Obeso
Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis.
Brain : a journal of neurology 1996;119 ( Pt 5)():1717-27.
1996: Patrick P Michel; Yves Agid
Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons.
Journal of neurochemistry 1996;67(4):1633-42.
1996: Angela Sirigu; J R Duhamel; laurent cohen; Bernard Pillon; Bruno Dubois; Yves Agid
The mental representation of hand movements after parietal cortex damage.
Science (New York, N.Y.) 1996;273(5281):1564-8.
1996: Yves Agid; Etienne C Hirsch; P Anglade; P Michel; Bernard Brugg; Merle Ruberg
Aging, disease and death of nerve cells.
Acta neurologica Belgica 1996;96(3):219-23.
1996: Thierry Billette de Villemeur; Jean-Philippe Deslys; A Pradel; C Soubrié; Annick Alpérovitch; M Tardieu; J L Chaussain; JEAN-JACQUES HAUW; Dominique Dormont; Merle Ruberg; Yves Agid
Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France.
Neurology 1996;47(3):690-5.
1996: F Boissière; Laurent Pradier; P Delaère; Baptiste A Faucheux; F Revah; Alexis Brice; Yves Agid; Etienne C Hirsch
Regional and cellular presenilin 2 (STM2) gene expression in the human brain.
Neuroreport 1996;7(12):2021-5.
1996: Dominique Campion; Alexis Brice; Didier Hannequin; Frédéric Charbonnier; Bruno Dubois; Cosette Martin; A Michon; C Penet; M Bellis; A Calenda; M Martinez; Yves Agid; Françoise Clerget-Darpoux; Thierry Frebourg
No founder effect in three novel Alzheimer's disease families with APP 717 Val-->Ile mutation. Clerget-darpoux. French Alzheimer's Disease Study Group.
Journal of medical genetics 1996;33(8):661-4.
1996: M Verny; Charles Duyckaerts; Yves Agid; JEAN-JACQUES HAUW
The significance of cortical pathology in progressive supranuclear palsy. Clinico-pathological data in 10 cases.
Brain : a journal of neurology 1996;119 ( Pt 4)():1123-36.
1996: Annick Mouatt-Prigent; J O Karlsson; Yves Agid; Etienne C Hirsch
Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?
Neuroscience 1996;73(4):979-87.
1996: Dominique Campion; Alexis Brice; Cécile Dumanchin; Michèle Puel; M Baulac; V De La Sayette; Didier Hannequin; Charles Duyckaerts; A Michon; Cosette Martin; V Moreau; C Penet; M Martinez; Françoise Clerget-Darpoux; Yves Agid; Thierry Frebourg
A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years.
Neuroreport 1996;7(10):1582-4.
1996: R Sherrington; S Froelich; Sandro Sorbi; Dominique Campion; H Chi; Ekaterina Rogaeva; Georges Levesque; Evgeny I Rogaev; C Lin; Yan Liang; Masaki Ikeda; L Mar; Alexis Brice; Yves Agid; M E Percy; F Clerget-Darpoux; Silvia Piacentini; Giordana Marcon; Benedetta Nacmias; Luigi Amaducci; Thierry Frebourg; Lars Lannfelt; Johanna M Rommens; Peter St George-Hyslop
Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant.
Human molecular genetics 1996;5(7):985-8.
1996: Shuichi Igarashi; Yoshihisa Takiyama; G Cancel; Ekaterina Rogaeva; H Sasaki; A Wakisaka; Y X Zhou; H Takano; K Endo; K Sanpei; Mutsuo Oyake; Hajime Tanaka; Giovanni Stevanin; Nacer Abbas; Alexandra Dürr; Evgeny I Rogaev; R Sherrington; T Tsuda; Masaki Ikeda; E Cassa; Masatoyo Nishizawa; Ali Benomar; J Julien; Jean Weissenbach; G X Wang; Yves Agid; Peter St George-Hyslop; Alexis Brice; S Tsuji
Intergenerational instability of the CAG repeat of the gene for Machado-Joseph disease (MJD1) is affected by the genotype of the normal chromosome: implications for the molecular mechanisms of the instability of the CAG repeat.
Human molecular genetics 1996;5(7):923-32.
1996: A Partiot; M Vérin; Bernard Pillon; C Teixeira-Ferreira; Yves Agid; Bruno Dubois
Delayed response tasks in basal ganglia lesions in man: further evidence for a striato-frontal cooperation in behavioural adaptation.
Neuropsychologia 1996;34(7):709-21.
1996: María-Trinidad Herrero; R Levy; Merle Ruberg; Maria Rosario Luquin; J Villares; J Guillen; Baptiste A Faucheux; France Javoy-Agid; J Guridi; Yves Agid; Jose A Obeso; Etienne C Hirsch
Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum.
Neurology 1996;47(1):219-24.
1996: I Litvan; Yves Agid; Donald B Calne; G Campbell; Bruno Dubois; RC Duvoisin; Christopher G Goetz; Lawrence I Golbe; Jordan Grafman; John H Growdon; Mark Hallett; Joseph Jankovic; Niall Quinn; E Tolosa; David S Zee
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.
Neurology 1996;47(1):1-9.
1996: P Anglade; Annick Mouatt-Prigent; Yves Agid; Etienne C Hirsch
Synaptic plasticity in the caudate nucleus of patients with Parkinson's disease.
Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration 1996;5(2):121-8.
1996: Angela Sirigu; Tiziana Zalla; Bernard Pillon; Jordan Grafman; Yves Agid; Bruno Dubois
Encoding of sequence and boundaries of scripts following prefrontal lesions.
Cortex; a journal devoted to the study of the nervous system and behavior 1996;32(2):297-310.
1996: J Lopes; Eric LeGuern; Riadh Gouider; Sandrine Tardieu; Nacer Abbas; Nazha Birouk; M Gugenheim; Pierre Bouche; Yves Agid; Alexis Brice
Recombination hot spot in a 3.2-kb region of the Charcot-Marie-Tooth type 1A repeat sequences: new tools for molecular diagnosis of hereditary neuropathy with liability to pressure palsies and of Charcot-Marie-Tooth type 1A. French CMT Collaborative Research Group.
American journal of human genetics 1996;58(6):1223-30.
1996: A F Carpentier; Anne-Marie Bonnet; Marie Vidailhet; Yves Agid
Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease.
Neurology 1996;46(6):1548-51.
1996: Véronique Bernard; A Gardiol; Baptiste A Faucheux; Bertrand Bloch; Yves Agid; Etienne C Hirsch
Expression of glutamate receptors in the human and rat basal ganglia: effect of the dopaminergic denervation on AMPA receptor gene expression in the striatopallidal complex in Parkinson's disease and rat with 6-OHDA lesion.
The Journal of comparative neurology 1996;368(4):553-68.
1996: F Boissière; Stéphane Lehéricy; O Strada; Yves Agid; Etienne C Hirsch
Neurotrophin receptors and selective loss of cholinergic neurons in Alzheimer disease.
Molecular and chemical neuropathology / sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid 1996;28(1-3):219-23.
1996: Stéphane Hunot; F Boissière; Baptiste A Faucheux; Bernard Brugg; Annick Mouatt-Prigent; Yves Agid; Etienne C Hirsch
Nitric oxide synthase and neuronal vulnerability in Parkinson's disease.
Neuroscience 1996;72(2):355-63.
1996: J P Brandel; M Vidailhet; G Noseda; J P Harpey; Yves Agid
Mycoplasma pneumoniae postinfectious encephalomyelitis with bilateral striatal necrosis.
Movement disorders : official journal of the Movement Disorder Society 1996;11(3):333-6.
1996: Agnes Lezin; G Cancel; Giovanni Stevanin; Didier Smadja; JC Vernant; Alexandra Dürr; Jenny Martial; G G Buisson; R Bellance; H Chneiweiss; Yves Agid; Alexis Brice
Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies): genetic analysis of three unrelated SCA2 families.
Human genetics 1996;97(5):671-6.
1996: Philippe Damier; A Kastner; Yves Agid; Etienne C Hirsch
Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease?
Neurology 1996;46(5):1262-9.
1996: I Litvan; Yves Agid; Joseph Jankovic; Christopher G Goetz; Jean-Philippe Brandel; EC Lai; Gregor Wenning; Luis D'Olhaberriague; M Verny; K Ray Chaudhuri; A McKee; Kurt A Jellinger; John J Bartko; Carlos A Mangone; RK Pearce
Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
Neurology 1996;46(4):922-30.
1996: Miquel Vila; R Levy; María-Trinidad Herrero; Baptiste A Faucheux; Jose A Obeso; Yves Agid; Etienne C Hirsch
Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: a cytochrome oxidase histochemistry study.
Neuroscience 1996;71(4):903-12.
1996: Alexandra Dürr; Giovanni Stevanin; G Cancel; Charles Duyckaerts; Nacer Abbas; O Didierjean; H Chneiweiss; Ali Benomar; Olivier Lyon-Caen; J Julien; M Serdaru; C Penet; Yves Agid; Alexis Brice
Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features.
Annals of neurology 1996;39(4):490-9.
1996: Stéphane Lehéricy; Marie Vidailhet; Dominique Dormont; L Piérot; Jacques Chiras; P Mazetti; Claude Marsault; Yves Agid
Striatopallidal and thalamic dystonia. A magnetic resonance imaging anatomoclinical study.
Archives of neurology 1996;53(3):241-50.
1996: H Rouger; Eric LeGuern; Riadh Gouider; Sandrine Tardieu; Nazha Birouk; M Gugenheim; Pierre Bouche; Yves Agid; Alexis Brice
High frequency of mutations in codon 98 of the peripheral myelin protein P0 gene in 20 French CMT1 patients.
American journal of human genetics 1996;58(3):638-41.
1996: Miquel Vila; María-Trinidad Herrero; R Levy; Baptiste A Faucheux; Merle Ruberg; J Guillen; Maria Rosario Luquin; J Guridi; France Javoy-Agid; Yves Agid; Jose A Obeso; Etienne C Hirsch
Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes.
Neurology 1996;46(3):802-9.
1996: V Blanchard; P Anglade; G Dziewczapolski; M Savasta; Yves Agid; Rita Raisman-Vozari
Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra.
Brain research 1996;709(2):319-25.
1996: M Martinez; Dominique Campion; Marie-Claude Babron; Didier Hannequin; Yves Agid; M Bellis; Alexis Brice; J Mallet; A Michon; Catherine Thomas-Anterion; Françoise Clerget-Darpoux
Segregation analysis of Alzheimer pedigrees: rare Mendelian dominant mutation(s) explain a minority of early-onset cases. French Alzheimer Collaborative Group.
American journal of medical genetics 1996;67(1):9-12.
1996: AI Vermersch; René Martin Mueri; Sophie Rivaud; Marie Vidailhet; Bertrand Gaymard; Yves Agid; Charles Pierrot-Deseilligny
Saccade disturbances after bilateral lentiform nucleus lesions in humans.
Journal of neurology, neurosurgery, and psychiatry 1996;60(2):179-84.
1996: B Pillon; Bruno Dubois; Yves Agid
Testing cognition may contribute to the diagnosis of movement disorders.
Neurology 1996;46(2):329-34.
1996: Bernard Brugg; Patrick P Michel; Yves Agid; Merle Ruberg
Ceramide induces apoptosis in cultured mesencephalic neurons.
Journal of neurochemistry 1996;66(2):733-9.
1996: Stéphane Hunot; Véronique Bernard; Baptiste A Faucheux; F Boissière; Eric LeGuern; C Brana; P P Gautris; J Guérin; Bertrand Bloch; Yves Agid; Etienne C Hirsch
Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: a post mortem in situ hybridization study with special reference to Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(8-9):1043-52.
1996: M Verny; Kurt A Jellinger; JEAN-JACQUES HAUW; Christian Bancher; I Litvan; Yves Agid
Progressive supranuclear palsy: a clinicopathological study of 21 cases.
Acta neuropathologica 1996;91(4):427-31.
1996: Didier Hannequin; Dominique Campion; Alexis Brice; Thierry Frebourg; M Martinez; F Clerget-Darpoux; Yves Agid
[Genetics of Alzheimer's disease].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1996;17(7):545-50.
1996: Bernard Pillon; S Ertle; Bernard Deweer; M Sarazin; Yves Agid; Bruno Dubois
Memory for spatial location is affected in Parkinson's disease.
Neuropsychologia 1996;34(1):77-85.
1996: B Pillon; Bruno Dubois; Yves Agid
Cognitive deficits in non-Alzheimer's degenerative diseases.
Journal of neural transmission. Supplementum 1996;47():61-71.
1996: Eric LeGuern; Riadh Gouider; Nicole Ravisé; J Lopes; Sandrine Tardieu; M Gugenheim; Nacer Abbas; Pierre Bouche; Yves Agid; Alexis Brice
A de novo case of hereditary neuropathy with liability to pressure palsies (HNPP) of maternal origin: a new mechanism for deletion in 17p11.2?
Human molecular genetics 1996;5(1):103-6.
1996: B Leveugle; Baptiste A Faucheux; Constantin Bouras; N Nillesse; Geneviève Spik; Etienne C Hirsch; Yves Agid; Patrick R Hof
Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases.
Acta neuropathologica 1996;91(6):566-72.
1996: María-Trinidad Herrero; R Levy; Merle Ruberg; France Javoy-Agid; Maria Rosario Luquin; Yves Agid; Etienne C Hirsch; Jose A Obeso
Glutamic acid decarboxylase mRNA expression in medial and lateral pallidal neurons in the MPTP-treated monkey and patients with Parkinson's disease.
Advances in neurology 1996;69():209-16.
1996: P Anglade; V Blanchard; Rita Raisman-Vozari; Baptiste A Faucheux; María-Trinidad Herrero; Jose A Obeso; Annick Mouatt-Prigent; A Kastner; O Strada; France Javoy-Agid; Yves Agid; Etienne C Hirsch
Is dopaminergic cell death accompanied by concomitant nerve plasticity?
Advances in neurology 1996;69():195-208.
1996: Eric LeGuern; N Ravise; Riadh Gouider; M Gugenheim; J Lopes; Pierre Bouche; Yves Agid; Alexis Brice
Microsatellite mapping of the deletion in patients with hereditary neuropathy with liability to pressure palsies (HNPP): new molecular tools for the study of the region 17p12 --> p11 and for diagnosis.
Cytogenetics and cell genetics 1996;72(1):20-5.
1995: Jordi Pérez-Tur; Dominique Campion; M Martinez; Alexis Brice; Sandrine Tardieu; Didier Hannequin; Yves Agid; André Delacourte; Françoise Clerget-Darpoux; Marie-Christine Chartier-Harlin
Evidence for apolipoprotein E epsilon 4 association in early-onset Alzheimer's patients with late-onset relatives.
American journal of medical genetics 1995;60(6):550-3.
1995: Bruno Dubois; R Levy; M Verin; C Teixeira; Yves Agid; Bernard Pillon
Experimental approach to prefrontal functions in humans.
Annals of the New York Academy of Sciences 1995;769():41-60.
1995: Angela Sirigu; Tiziana Zalla; Bernard Pillon; Jordan Grafman; Bruno Dubois; Yves Agid
Planning and script analysis following prefrontal lobe lesions.
Annals of the New York Academy of Sciences 1995;769():277-88.
1995: Didier Hannequin; Dominique Campion; Sandrine Tardieu; Pascal Auzou; M Martinez; Bruno Dubois; Françoise Clerget-Darpoux; Yves Agid; Alexis Brice
[Phenotype of familial forms of early-onset Alzheimer's disease linked to chromosome 14. Clinical and neuropsychological characteristics of a large group].
Revue neurologique 1995;151(12):682-90.
1995: J Blin; P Mazetti; Bernard Mazoyer; Sophie Rivaud; S Ben Ayed; Chara Malapani; Bernard Pillon; Yves Agid
Does the enhancement of cholinergic neurotransmission influence brain glucose kinetics and clinical symptomatology in progressive supranuclear palsy?
Brain : a journal of neurology 1995;118 ( Pt 6)():1485-95.
1995: Philippe Remy; H Hosseini; J D Degos; Yves Samson; Yves Agid; J M Warter; M Vidailhet
Striatal dopaminergic denervation in pallidopyramidal disease demonstrated by positron emission tomography.
Annals of neurology 1995;38(6):954-6.
1995: O Dubourg; Alexandra Dürr; H Chneiweiss; Giovanni Stevanin; G Cancel; C Penet; Yves Agid; Alexis Brice
[Does the ataxo-choreic form of DRPLA exist in Europe? Search of mutation in 120 families].
Revue neurologique 1995;151(11):657-60.
1995: Riadh Gouider; Eric LeGuern; M Gugenheim; Sandrine Tardieu; Thierry Maisonobe; Jean-Marc Léger; Jean-Michel Vallat; Yves Agid; Pierre Bouche; Alexis Brice
Clinical, electrophysiologic, and molecular correlations in 13 families with hereditary neuropathy with liability to pressure palsies and a chromosome 17p11.2 deletion.
Neurology 1995;45(11):2018-23.
1995: Giovanni Stevanin; G Cancel; O Didierjean; Alexandra Dürr; Nacer Abbas; E Cassa; J Feingold; Yves Agid; Alexis Brice
Linkage disequilibrium at the Machado-Joseph disease/spinal cerebellar ataxia 3 locus: evidence for a common founder effect in French and Portuguese-Brazilian families as well as a second ancestral Portuguese-Azorean mutation.
American journal of human genetics 1995;57(5):1247-50.
1995: R Levy; Miquel Vila; María-Trinidad Herrero; Baptiste A Faucheux; Yves Agid; Etienne C Hirsch
Striatal expression of substance P and methionin-enkephalin in genes in patients with Parkinson's disease.
Neuroscience letters 1995;199(3):220-4.
1995: Baptiste A Faucheux; N Nillesse; Philippe Damier; Geneviève Spik; Annick Mouatt-Prigent; Annick Pierce; B Leveugle; N Kubis; JEAN-JACQUES HAUW; Yves Agid
Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(21):9603-7.
1995: G Cancel; Giovanni Stevanin; Alexandra Dürr; H Chneiweiss; C Penet; Y Pothin; Yves Agid; Alexis Brice
SCA2 is not a major locus for ADCA type I in French families.
American journal of medical genetics 1995;60(5):382-5.
1995: Giovanni Stevanin; E Cassa; G Cancel; Nacer Abbas; Alexandra Dürr; E Jardim; Yves Agid; P S Sousa; Alexis Brice
Characterisation of the unstable expanded CAG repeat in the MJD1 gene in four Brazilian families of Portuguese descent with Machado-Joseph disease.
Journal of medical genetics 1995;32(10):827-30.
1995: María-Trinidad Herrero; S J Augood; Etienne C Hirsch; France Javoy-Agid; Maria Rosario Luquin; Yves Agid; Jose A Obeso; P C Emson
Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum.
Neuroscience 1995;68(4):1189-98.
1995: G Cancel; Nacer Abbas; Giovanni Stevanin; Alexandra Dürr; H Chneiweiss; C Néri; Charles Duyckaerts; C Penet; H M Cann; Yves Agid
Marked phenotypic heterogeneity associated with expansion of a CAG repeat sequence at the spinocerebellar ataxia 3/Machado-Joseph disease locus.
American journal of human genetics 1995;57(4):809-16.
1995: Alexandra Dürr; Giovanni Stevanin; G Cancel; Nacer Abbas; H Chneiweiss; Yves Agid; J Feingold; Alexis Brice
Gender equality in Machado-Joseph disease.
Nature genetics 1995;11(2):118-9.
1995: Franck Durif; Marie Vidailhet; Anne-Marie Bonnet; J Blin; Yves Agid
Levodopa-induced dyskinesias are improved by fluoxetine.
Neurology 1995;45(10):1855-8.
1995: Florence Thibaut; Baptiste A Faucheux; J Marquez; J Villares; J F Menard; Yves Agid; Etienne C Hirsch
Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine.
Brain research 1995;692(1-2):233-43.
1995: Baptiste A Faucheux; María-Trinidad Herrero; J Villares; R Levy; France Javoy-Agid; Jose A Obeso; JEAN-JACQUES HAUW; Yves Agid; Etienne C Hirsch
Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys.
Brain research 1995;691(1-2):115-24.
1995: Anne-Marie Bonnet; I Serre; Roberto Marconi; Yves Agid; Bruno Dubois
A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine.
Movement disorders : official journal of the Movement Disorder Society 1995;10(5):668-71.
1995: Bernard Pillon; J Blin; Marie Vidailhet; Bernard Deweer; Angela Sirigu; Bruno Dubois; Yves Agid
The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease.
Neurology 1995;45(8):1477-83.
1995: Yves Agid
[Aging, disease and nerve cell death].
Bulletin de l'Académie nationale de médecine 1995;179(6):1193-203; discussion 1203-7.
1995: Angela Sirigu; Tiziana Zalla; Bernard Pillon; Jordan Grafman; Yves Agid; Bruno Dubois
Selective impairments in managerial knowledge following pre-frontal cortex damage.
Cortex; a journal devoted to the study of the nervous system and behavior 1995;31(2):301-16.
1995: Angela Sirigu; laurent cohen; J R Duhamel; Bernard Pillon; Bruno Dubois; Yves Agid; C Pierrot-Deseilligny
Congruent unilateral impairments for real and imagined hand movements.
Neuroreport 1995;6(7):997-1001.
1995: Bernard Deweer; Stéphane Lehéricy; Bernard Pillon; Michel Baulac; Jacques Chiras; Claude Marsault; Yves Agid; Bruno Dubois
Memory disorders in probable Alzheimer's disease: the role of hippocampal atrophy as shown with MRI.
Journal of neurology, neurosurgery, and psychiatry 1995;58(5):590-7.
1995: N Gouider-Khouja; Marie Vidailhet; Anne-Marie Bonnet; J Pichon; Yves Agid
"Pure" striatonigral degeneration and Parkinson's disease: a comparative clinical study.
Movement disorders : official journal of the Movement Disorder Society 1995;10(3):288-94.
1995: Yvon Trottier; Didier Devys; G Imbert; Frédéric Saudou; I An; Yves Lutz; C Weber; Yves Agid; Etienne C Hirsch; Jean-Louis Mandel
Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form.
Nature genetics 1995;10(1):104-10.
1995: Christophe Pêcheux; J F Mouret; Alexandra Dürr; Yves Agid; J Feingold; Alexis Brice; Catherine Dodé; Jean-Claude Kaplan
Sequence analysis of the CCG polymorphic region adjacent to the CAG triplet repeat of the HD gene in normal and HD chromosomes.
Journal of medical genetics 1995;32(5):399-400.
1995: Patrick P Michel; Yves Agid
Death of septal cholinergic neurons produced by chronic exposure to glutamate is prevented by the noncompetitive NMDA receptor/channel antagonist, MK-801: role of nerve growth factor and nitric oxide.
Journal of neuroscience research 1995;40(6):764-75.
1995: V Blanchard; M Chritin; Sheela Vyas; M Savasta; Claude Feuerstein; Yves Agid; France Javoy-Agid; Rita Raisman-Vozari
Long-term induction of tyrosine hydroxylase expression: compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain.
Journal of neurochemistry 1995;64(4):1669-79.
1995: Angela Sirigu; laurent cohen; J R Duhamel; Bernard Pillon; Bruno Dubois; Yves Agid
A selective impairment of hand posture for object utilization in apraxia.
Cortex; a journal devoted to the study of the nervous system and behavior 1995;31(1):41-55.
1995: Alexandra Dürr; Catherine Dodé; V Hahn; Christophe Pêcheux; Bernard Pillon; J Feingold; Jean-Claude Kaplan; Yves Agid; Alexis Brice
Diagnosis of "sporadic" Huntington's disease.
Journal of the neurological sciences 1995;129(1):51-5.
1995: Bernard Pillon; N Gouider-Khouja; Bernard Deweer; Marie Vidailhet; Chara Malapani; Bruno Dubois; Yves Agid
Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy.
Journal of neurology, neurosurgery, and psychiatry 1995;58(2):174-9.
1995: Merle Ruberg; D Scherman; France Javoy-Agid; Yves Agid
Dopamine denervation, age of onset, and Parkinson's disease.
Neurology 1995;45(2):392.
1995: P Anglade; S Tsuji; France Javoy-Agid; Yves Agid; Etienne C Hirsch
Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease.
Annals of neurology 1995;37(2):265-72.
1995: O Dubourg; Alexandra Dürr; G Cancel; Giovanni Stevanin; H Chneiweiss; C Penet; Yves Agid; Alexis Brice
Analysis of the SCA1 CAG repeat in a large number of families with dominant ataxia: clinical and molecular correlations.
Annals of neurology 1995;37(2):176-80.
1995: Patrick P Michel; Sheela Vyas; Yves Agid
Synergistic differentiation by chronic exposure to cyclic AMP and nerve growth factor renders rat phaeochromocytoma PC12 cells totally dependent upon trophic support for survival.
The European journal of neuroscience 1995;7(2):251-60.
1995: P Anglade; S Tsuji; Yves Agid; Etienne C Hirsch
Neuronal plasticity and Parkinson disease.
Molecular and chemical neuropathology / sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid 1995;24(2-3):251-5.
1995: Giovanni Stevanin; G Cancel; Alexandra Dürr; H Chneiweiss; O Dubourg; Jean Weissenbach; H M Cann; Yves Agid; Alexis Brice
The gene for spinal cerebellar ataxia 3 (SCA3) is located in a region of approximately 3 cM on chromosome 14q24.3-q32.2.
American journal of human genetics 1995;56(1):193-201.
1995: R Levy; Merle Ruberg; María-Trinidad Herrero; J Villares; France Javoy-Agid; Yves Agid; Etienne C Hirsch
Alterations of GABAergic neurons in the basal ganglia of patients with progressive supranuclear palsy: an in situ hybridization study of GAD67 messenger RNA.
Neurology 1995;45(1):127-34.
1995: Bertrand Fontaine; C S Rime; Jamilé Hazan; Alexandra Dürr; Giovanni Stevanin; C Penet; J Reboul; Yves Agid; Olivier Lyon-Caen; N Baumann
Exclusion of the candidate locus FSP1 in six families with late-onset autosomal dominant spastic paraplegia.
Neuromuscular disorders : NMD 1995;5(1):11-7.
1995: T Billette de Villemeur; Yves Agid
[Iatrogenic Creutzfedt-Jacob disease. What precautions are to be taken for the prevention of neurosurgical contamination?].
Neuro-Chirurgie 1995;41(1):1-2.
1995: Alexandra Dürr; Alexis Brice; A Lepage-Lezin; G Cancel; Didier Smadja; JC Vernant; Yves Agid
Autosomal dominant cerebellar ataxia type I linked to chromosome 12q (SCA2: spinocerebellar ataxia type 2).
Clinical neuroscience (New York, N.Y.) 1995;3(1):12-6.
1994: Annick Mouatt-Prigent; Yves Agid; Etienne C Hirsch
Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?
Brain research 1994;668(1-2):62-70.
1994: J P Brandel; R Marconi; M Serdaru; M Vidailhet; Yves Agid
Down's syndrome and Parkinson's disease.
Neurology 1994;44(12):2419-20.
1994: Riadh Gouider; Eric LeGuern; J Emile; Sandrine Tardieu; F Cabon; M Samid; Jean Weissenbach; Yves Agid; Pierre Bouche; Alexis Brice
Hereditary neuralgic amyotrophy and hereditary neuropathy with liability to pressure palsies: two distinct clinical, electrophysiologic, and genetic entities.
Neurology 1994;44(12):2250-2.
1994: J Villares; O Strada; Baptiste A Faucheux; France Javoy-Agid; Yves Agid; Etienne C Hirsch
Loss of striatal high affinity NGF binding sites in progressive supranuclear palsy but not in Parkinson's disease.
Neuroscience letters 1994;182(1):59-62.
1994: Giovanni Stevanin; P S Sousa; G Cancel; Alexandra Dürr; O Dubourg; G A Nicholson; Jean Weissenbach; E Jardim; Yves Agid; E Cassa
The gene for Machado-Joseph disease maps to the same 3-cM interval as the spinal cerebellar ataxia 3 gene on chromosome 14q.
Neurobiology of disease 1994;1(1-2):79-82.
1994: F Boissière; Stéphane Hunot; Baptiste A Faucheux; Annick Mouatt-Prigent; Yves Agid; Etienne C Hirsch
High affinity neurotrophin receptors in cholinergic neurons in the human brain.
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1994;317(11):997-1003.
1994: Stéphane Lehéricy; Jean-Philippe Brandel; Etienne C Hirsch; P Anglade; J Villares; D Scherman; Charles Duyckaerts; France Javoy-Agid; Yves Agid
Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography.
Brain research 1994;659(1-2):1-9.
1994: jeswinder sian; David T Dexter; Andrew J Lees; Susan E Daniel; Yves Agid; France Javoy-Agid; Peter Jenner; CD Marsden
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
Annals of neurology 1994;36(3):348-55.
1994: Marie Vidailhet; Anne-Marie Bonnet; Roberto Marconi; N Gouider-Khouja; Yves Agid
Do parkinsonian symptoms and levodopa-induced dyskinesias start in the foot?
Neurology 1994;44(9):1613-6.
1994: E Le Guern; N Ravise; M Gugenheim; A Vignal; C Penet; Pierre Bouche; Jean Weissenbach; Yves Agid; Alexis Brice
Linkage analyses between dominant X-linked Charcot-Marie-Tooth disease, and 15 Xq11-Xq21 microsatellites in a new large family: three new markers are closely linked to the gene.
Neuromuscular disorders : NMD 1994;4(5-6):463-9.
1994: Jamilé Hazan; Bertrand Fontaine; R P Bruyn; C Lamy; Judith C T van Deutekom; C S Rime; Alexandra Dürr; Judith Melki; Olivier Lyon-Caen; Yves Agid
Linkage of a new locus for autosomal dominant familial spastic paraplegia to chromosome 2p.
Human molecular genetics 1994;3(9):1569-73.
1994: A Kastner; P Anglade; C Bounaix; Philippe Damier; France Javoy-Agid; N Bromet; Yves Agid; Etienne C Hirsch
Immunohistochemical study of catechol-O-methyltransferase in the human mesostriatal system.
Neuroscience 1994;62(2):449-57.
1994: Sheela Vyas; Patrick P Michel; M C Copin; Nicole Faucon Biguet; M Thomasset; Yves Agid
Induction of calbindin-D 28K gene and protein expression by physiological stimuli but not in calcium-mediated degeneration in rat PC12 pheochromocytoma cells.
FEBS letters 1994;351(1):53-7.
1994: Samir Belal; G Cancel; Giovanni Stevanin; Faycal Hentati; C Khati; Christiane Ben Hamida; Georg Auburger; Yves Agid; Mongi Ben Hamida; Alexis Brice
Clinical and genetic analysis of a Tunisian family with autosomal dominant cerebellar ataxia type 1 linked to the SCA2 locus.
Neurology 1994;44(8):1423-6.
1994: A Kastner; María-Trinidad Herrero; Etienne C Hirsch; J Guillen; Maria Rosario Luquin; France Javoy-Agid; Jose A Obeso; Yves Agid
Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy.
Annals of neurology 1994;36(2):206-14.
1994: P Dournaud; P Cervera-Pierot; Etienne C Hirsch; France Javoy-Agid; Claude Kordon; Yves Agid; Jacques Epelbaum
Somatostatin messenger RNA-containing neurons in Alzheimer's disease: an in situ hybridization study in hippocampus, parahippocampal cortex and frontal cortex.
Neuroscience 1994;61(4):755-64.
1994: Alexandra Dürr; Alexis Brice; M Serdaru; G Rancurel; C Derouesné; Olivier Lyon-Caen; Yves Agid; B Fontaine
The phenotype of "pure" autosomal dominant spastic paraplegia.
Neurology 1994;44(7):1274-7.
1994: Bernard Pillon; Bernard Deweer; A Michon; Chara Malapani; Yves Agid; Bruno Dubois
Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer's, Parkinson's, and Huntington's diseases.
Neurology 1994;44(7):1264-70.
1994: P Mazzetti; E Le Guern; Anne-Marie Bonnet; M Vidailhet; Alexis Brice; Yves Agid
Familial Parkinson's disease and polymorphism at the CYP2D6 locus.
Journal of neurology, neurosurgery, and psychiatry 1994;57(7):871-2.
1994: A Michon; Bernard Deweer; Bernard Pillon; Yves Agid; Bruno Dubois
Relation of anosognosia to frontal lobe dysfunction in Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 1994;57(7):805-9.
1994: P Zhang; P Anglade; Etienne C Hirsch; France Javoy-Agid; Yves Agid
Distribution of manganese-dependent superoxide dismutase in the human brain.
Neuroscience 1994;61(2):317-30.
1994: G Boka; P Anglade; David Wallach; France Javoy-Agid; Yves Agid; Etienne C Hirsch
Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease.
Neuroscience letters 1994;172(1-2):151-4.
1994: S Holemans; France Javoy-Agid; Yves Agid; F De Paermentier; E C Laterre; Jean-Marie Maloteaux
Sulfonylurea binding sites in normal human brain and in Parkinson's disease, progressive supranuclear palsy and Huntington's disease.
Brain research 1994;642(1-2):327-33.
1994: S Malessa; Bertrand Gaymard; Sophie Rivaud; P Cervera; Etienne C Hirsch; M Verny; Charles Duyckaerts; Yves Agid; Charles Pierrot-Deseilligny
Role of pontine nuclei damage in smooth pursuit impairment of progressive supranuclear palsy: a clinical-pathologic study.
Neurology 1994;44(4):716-21.
1994: AI Vermersch; Sophie Rivaud; Marie Vidailhet; Anne-Marie Bonnet; Bertrand Gaymard; Yves Agid; Charles Pierrot-Deseilligny
Sequences of memory-guided saccades in Parkinson's disease.
Annals of neurology 1994;35(4):487-90.
1994: Ali Benomar; E Le Guern; Alexandra Dürr; H Ouhabi; Giovanni Stevanin; Mohamed Yahyaoui; Taïeb Chkili; Yves Agid; Alexis Brice
Autosomal-dominant cerebellar ataxia with retinal degeneration (ADCA type II) is genetically different from ADCA type I.
Annals of neurology 1994;35(4):439-44.
1994: Marie Vidailhet; Sophie Rivaud; N Gouider-Khouja; Bernard Pillon; Anne-Marie Bonnet; Bertrand Gaymard; Yves Agid; Charles Pierrot-Deseilligny
Eye movements in parkinsonian syndromes.
Annals of neurology 1994;35(4):420-6.
1994: Patrick P Michel; Sheela Vyas; P Anglade; Merle Ruberg; Yves Agid
Morphological and molecular characterization of the response of differentiated PC12 cells to calcium stress.
The European journal of neuroscience 1994;6(4):577-86.
1994: Bernard Deweer; A M Ergis; P Fossati; Bernard Pillon; François Boller; Yves Agid; Bruno Dubois
Explicit memory, procedural learning and lexical priming in Alzheimer's disease.
Cortex; a journal devoted to the study of the nervous system and behavior 1994;30(1):113-26.
1994: V Blanchard; Rita Raisman-Vozari; Sheela Vyas; Patrick P Michel; France Javoy-Agid; George R. Uhl; Yves Agid
Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon.
Brain research. Molecular brain research 1994;22(1-4):29-38.
1994: Chara Malapani; Bernard Pillon; Bruno Dubois; Yves Agid
Impaired simultaneous cognitive task performance in Parkinson's disease: a dopamine-related dysfunction.
Neurology 1994;44(2):319-26.
1994: Roberto Marconi; D Lefebvre-Caparros; Anne-Marie Bonnet; Marie Vidailhet; Bruno Dubois; Yves Agid
Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
Movement disorders : official journal of the Movement Disorder Society 1994;9(1):2-12.
1994: G Cancel; Alexandra Dürr; Giovanni Stevanin; H Chneiweiss; Charles Duyckaerts; M Serdaru; B de Toffol; Yves Agid; Alexis Brice
Is DRPLA also linked to 14q?
Nature genetics 1994;6(1):8.
1994: H Petit; Yves Agid
[Information on the consequences of the discovery of the Huntington disease gene].
Revue neurologique 1994;150(5):338-9.
1993: Alexandra Dürr; H Chneiweiss; C Khati; Giovanni Stevanin; G Cancel; J Feingold; Yves Agid; Alexis Brice
Phenotypic variability in autosomal dominant cerebellar ataxia type I is unrelated to genetic heterogeneity.
Brain : a journal of neurology 1993;116 ( Pt 6)():1497-508.
1993: O Strada; Etienne C Hirsch; France Javoy-Agid; Charles Duyckaerts; JEAN-JACQUES HAUW; Yves Agid
Low affinity nerve growth factor receptor, adrenal transplant and Parkinson's disease.
Journal of the neurological sciences 1993;120(1):33-7.
1993: M Verin; A Partiot; Bernard Pillon; Chara Malapani; Yves Agid; Bruno Dubois
Delayed response tasks and prefrontal lesions in man--evidence for self generated patterns of behaviour with poor environmental modulation.
Neuropsychologia 1993;31(12):1379-96.
1993: J Villares; Baptiste A Faucheux; O Strada; Etienne C Hirsch; Yves Agid; France Javoy-Agid
Autoradiographic study of [125I]epidermal growth factor-binding sites in the mesencephalon of control and parkinsonian brains post-mortem.
Brain research 1993;628(1-2):72-6.
1993: Alexandra Dürr; Giovanni Stevanin; C P Jedynak; C Penet; Yves Agid; Alexis Brice
Familial essential tremor and idiopathic torsion dystonia are different genetic entities.
Neurology 1993;43(11):2212-4.
1993: Catherine Dodé; Alexandra Dürr; Christophe Pêcheux; J F Mouret; Samir Belal; L Bachner; Yves Agid; Jean-Claude Kaplan; Alexis Brice; J Feingold
Huntington's disease in French families: CAG repeat expansion and linkage disequilibrium analysis.
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1993;316(11):1374-80.
1993: María-Trinidad Herrero; Etienne C Hirsch; France Javoy-Agid; Jose A Obeso; Yves Agid
Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum.
Brain research 1993;624(1-2):281-5.
1993: María-Trinidad Herrero; A Kastner; I Perez-Otaño; Etienne C Hirsch; Maria Rosario Luquin; France Javoy-Agid; J Del Río; Jose A Obeso; Yves Agid
Gangliosides and parkinsonism.
Neurology 1993;43(10):2132-4.
1993: María-Trinidad Herrero; I Perez-Otaño; C Oset; A Kastner; Etienne C Hirsch; Yves Agid; Maria Rosario Luquin; Jose A Obeso; J Del Rio
GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys.
Neuroscience 1993;56(4):965-72.
1993: María-Trinidad Herrero; Etienne C Hirsch; A Kastner; Merle Ruberg; Maria Rosario Luquin; J Laguna; France Javoy-Agid; Jose A Obeso; Yves Agid
Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?
Neuroscience 1993;56(2):499-511.
1993: Giovanni Stevanin; H Chneiweiss; E Le Guern; N Ravise; Alexandra Dürr; C Penet; Yves Agid; Alexis Brice
Genetic heterogeneity of autosomal dominant cerebellar ataxia type I: evidence for the existence of a third locus.
Human molecular genetics 1993;2(9):1483-5.
1993: G Cancel; C Khati; Giovanni Stevanin; J C Pages; Yves Agid; Alexis Brice; H M Cann
Endothelin 1 is not a candidate gene for spinal cerebellar ataxia 1.
Human molecular genetics 1993;2(9):1477-9.
1993: A Kastner; Etienne C Hirsch; María-Trinidad Herrero; France Javoy-Agid; Yves Agid
Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease.
Journal of neurochemistry 1993;61(3):1024-34.
1993: V Blanchard; Rita Raisman-Vozari; M Savasta; Etienne C Hirsch; France Javoy-Agid; Claude Feuerstein; Yves Agid
Cellular quantification of tyrosine hydroxylase in the rat brain by immunoautoradiography.
Journal of neurochemistry 1993;61(2):617-26.
1993: María-Trinidad Herrero; Merle Ruberg; Etienne C Hirsch; A Mouatt; A J Tobin; Yves Agid; Jose A Obeso; France Javoy-Agid
In situ hybridization of GAD mRNA in monkey and human brain: quantification at both regional and cellular levels.
Neuroscience letters 1993;157(1):57-61.
1993: P Zhang; Philippe Damier; Etienne C Hirsch; Yves Agid; Irène Ceballos-Picot; Pierre-Marie Sinet; Annie Nicole; M Laurent; France Javoy-Agid
Preferential expression of superoxide dismutase messenger RNA in melanized neurons in human mesencephalon.
Neuroscience 1993;55(1):167-75.
1993: P Anglade; S Tsuji; Etienne C Hirsch; France Javoy-Agid; Yves Agid
Ultrastructural relations between nigrostriatal dopaminergic neurons and cholinergic nerve endings in the human brain.
Histology and histopathology 1993;8(3):501-4.
1993: J Blin; Jean-Claude Baron; Bruno Dubois; Christian Crouzel; Marco Fiorelli; Dominique Attar-Lévy; Bernard Pillon; D Fournier; Marie Vidailhet; Yves Agid
Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone.
Brain : a journal of neurology 1993;116 ( Pt 3)():497-510.
1993: Baptiste A Faucheux; Etienne C Hirsch; J Villares; F Selimi; Annick Mouatt-Prigent; France Javoy-Agid; JEAN-JACQUES HAUW; Yves Agid
Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease.
Journal of neurochemistry 1993;60(6):2338-41.
1993: C Khati; Giovanni Stevanin; A Durr; H Chneiweiss; Samir Belal; A Seck; H Cann; Alexis Brice; Yves Agid
Genetic heterogeneity of autosomal dominant cerebellar ataxia type 1: clinical and genetic analysis of 10 French families.
Neurology 1993;43(6):1131-7.
1993: P Anglade; Etienne C Hirsch; Jean-Philippe Brandel; France Javoy-Agid; Charles Duyckaerts; JEAN-JACQUES HAUW; Yves Agid
Adrenal transplant, dopaminergic neurons, and Parkinson's disease.
Annals of neurology 1993;33(6):662-3.
1993: Patrick Vermersch; André Delacourte; France Javoy-Agid; JEAN-JACQUES HAUW; Yves Agid
Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins.
Annals of neurology 1993;33(5):445-50.
1993: S Lehéricy; Etienne C Hirsch; P Cervera-Piérot; Louis B Hersh; S Bakchine; F Piette; Charles Duyckaerts; JEAN-JACQUES HAUW; France Javoy-Agid; Yves Agid
Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease.
The Journal of comparative neurology 1993;330(1):15-31.
1993: Bernard Pillon; Bernard Deweer; Yves Agid; Bruno Dubois
Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases.
Archives of neurology 1993;50(4):374-9.
1993: A Kastner; Etienne C Hirsch; Yves Agid; France Javoy-Agid
Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease.
Brain research 1993;606(2):341-5.
1993: D Carter; Dominique Campion; Thierry d'Amato; M Jay; Alexis Brice; M Bellis; J Mallet; Yves Agid
No mutation in codon 713 of the amyloid precursor gene in schizophrenic patients.
Human molecular genetics 1993;2(3):321.
1993: Philippe Damier; Etienne C Hirsch; P Zhang; Yves Agid; France Javoy-Agid
Glutathione peroxidase, glial cells and Parkinson's disease.
Neuroscience 1993;52(1):1-6.
1993: Alexis Brice; A L Boch; Giovanni Stevanin; C Khati; Bruno Dubois; Yves Agid; Dominique Campion; F Clerget; J Mallet; M Bellis
Absence of the amyloid precursor protein gene mutation (APP717: Val->Ile) in 85 cases of early onset Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 1993;56(1):112-3.
1993: Yves Agid; Merle Ruberg; France Javoy-Agid; Etienne C Hirsch; Rita Raisman-Vozari; Sheela Vyas; Baptiste A Faucheux; P Michel; A Kastner; V Blanchard
Are dopaminergic neurons selectively vulnerable to Parkinson's disease?
Advances in neurology 1993;60():148-64.
1993: Yves Agid
[Mechanism of cell death in neurodegenerative disorders: apropos of Parkinson disease].
Comptes rendus des séances de la Société de biologie et de ses filiales 1993;187(1):37-46.
1993: María-Trinidad Herrero; Etienne C Hirsch; A Kastner; Maria Rosario Luquin; France Javoy-Agid; LM Gonzalo; Jose A Obeso; Yves Agid
Neuromelanin accumulation with age in catecholaminergic neurons from Macaca fascicularis brainstem.
Developmental neuroscience 1993;15(1):37-48.
1992: Patrick P Michel; Yves Agid
The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures.
Brain research 1992;597(2):233-40.
1992: O Strada; Etienne C Hirsch; France Javoy-Agid; Stéphane Lehéricy; Merle Ruberg; JEAN-JACQUES HAUW; Yves Agid
Does loss of nerve growth factor receptors precede loss of cholinergic neurons in Alzheimer's disease? An autoradiographic study in the human striatum and basal forebrain.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1992;12(12):4766-74.
1992: D A Carter; E Desmarais; M Bellis; D Campion; F Clerget-Darpoux; Alexis Brice; Yves Agid; A Jaillard-Serradt; J Mallet
More missense in amyloid gene.
Nature genetics 1992;2(4):255-6.
1992: Roberto Marconi; Anne-Marie Bonnet; Marie Vidailhet; Yves Agid
The IMAO-B MDL 72.974 A in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1992;55(11):1096-7.
1992: Alexis Brice; Nicole Ravisé; Giovanni Stevanin; M Gugenheim; Pierre Bouche; C Penet; Yves Agid
Duplication within chromosome 17p11.2 in 12 families of French ancestry with Charcot-Marie-Tooth disease type 1a. The French CMT Research Group.
Journal of medical genetics 1992;29(11):807-12.
1992: O Strada; Sheela Vyas; Etienne C Hirsch; Merle Ruberg; Alexis Brice; Yves Agid; France Javoy-Agid
Decreased choline acetyltransferase mRNA expression in the nucleus basalis of Meynert in Alzheimer disease: an in situ hybridization study.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(20):9549-53.
1992: J Blin; Marie Vidailhet; Bernard Pillon; Bruno Dubois; J R Feve; Yves Agid
Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET.
Movement disorders : official journal of the Movement Disorder Society 1992;7(4):348-54.
1992: D Morvan; M Komajda; L D Doan; Alexis Brice; R Isnard; A Seck; P Lechat; Yves Agid; Y Grosgogeat
Cardiomyopathy in Friedreich's ataxia: a Doppler-echocardiographic study.
European heart journal 1992;13(10):1393-8.
1992: A Kastner; Etienne C Hirsch; O Lejeune; France Javoy-Agid; Olivier Rascol; Yves Agid
Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?
Journal of neurochemistry 1992;59(3):1080-9.
1992: Hugues Chabriat; M Levasseur; M Vidailhet; Christian Loc'h; B Mazière; MH Bourguignon; Anne-Marie Bonnet; Mônica Zilbovicius; C Raynaud; Yves Agid
In-vivo SPECT imaging of D2 receptor with iodine-iodolisuride: results in supranuclear palsy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(8):1481-5.
1992: Etienne C Hirsch; A Mouatt; B Faucheux; Anne-Marie Bonnet; France Javoy-Agid; Ann M Graybiel; Yves Agid
Dopamine, tremor, and Parkinson's disease.
Lancet 1992;340(8811):125-6.
1992: Patrick P Michel; Sheela Vyas; Yves Agid
Toxic effects of iron for cultured mesencephalic dopaminergic neurons derived from rat embryonic brains.
Journal of neurochemistry 1992;59(1):118-27.
1992: Klaus W Lange; France Javoy-Agid; Yves Agid; Peter Jenner; CD Marsden
Brain muscarinic cholinergic receptors in Huntington's disease.
Journal of neurology 1992;239(2):103-4.
1992: Bruno Dubois; B Pillon; Yves Agid
Deterioration of dopaminergic pathways and alterations in cognition and motor functions.
Journal of neurology 1992;239 Suppl 1():S9-12.
1992: M Emre; UK Rinne; A Rascol; Andrew J Lees; Yves Agid; X Lataste
Effects of a selective partial D1 agonist, CY 208-243, in de novo patients with Parkinson disease.
Movement disorders : official journal of the Movement Disorder Society 1992;7(3):239-43.
1992: G Ransmayr; P Cervera; Etienne C Hirsch; W Berger; W Fischer; Yves Agid
Alzheimer's disease: is the decrease of the cholinergic innervation of the hippocampus related to intrinsic hippocampal pathology?
Neuroscience 1992;47(4):843-51.
1991: S Holemans; France Javoy-Agid; Yves Agid; E C Laterre; Jean-Marie Maloteaux
[3H]MK-801 binding to NMDA glutamatergic receptors in Parkinson's disease and progressive supranuclear palsy.
Brain research 1991;565(1):154-7.
1991: S Malessa; Etienne C Hirsch; P Cervera; France Javoy-Agid; Charles Duyckaerts; JEAN-JACQUES HAUW; Yves Agid
Progressive supranuclear palsy: loss of choline-acetyltransferase-like immunoreactive neurons in the pontine reticular formation.
Neurology 1991;41(10):1593-7.
1991: Rita Raisman-Vozari; Etienne C Hirsch; France Javoy-Agid; C Vassort; M Savasta; Claude Feuerstein; J Thibault; Yves Agid
Quantitative autoradiography of tyrosine hydroxylase immunoreactivity in the rat brain.
Journal of neurochemistry 1991;57(4):1212-22.
1991: J Blin; Bruno Dubois; Anne-Marie Bonnet; Marie Vidailhet; M Brandabur; Yves Agid
Does ageing aggravate parkinsonian disability?
Journal of neurology, neurosurgery, and psychiatry 1991;54(9):780-2.
1991: David T Dexter; A Carayon; France Javoy-Agid; Yves Agid; F R Wells; Susan E Daniel; Andrew J Lees; Peter Jenner; CD Marsden
Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
Brain : a journal of neurology 1991;114 ( Pt 4)():1953-75.
1991: Charles Pierrot-Deseilligny; Sophie Rivaud; Bertrand Gaymard; Yves Agid
Cortical control of reflexive visually-guided saccades.
Brain : a journal of neurology 1991;114 ( Pt 3)():1473-85.
1991: Yves Agid
Parkinson's disease: pathophysiology.
Lancet 1991;337(8753):1321-4.
1991: Bernard Pillon; Bruno Dubois; A Ploska; Yves Agid
Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy.
Neurology 1991;41(5):634-43.
1991: Stéphane Lehéricy; Etienne C Hirsch; Louis B Hersh; Yves Agid
Cholinergic neuronal loss in the globus pallidus of Alzheimer disease patients.
Neuroscience letters 1991;123(2):152-5.
1991: Etienne C Hirsch; Jean-Philippe Brandel; P Galle; France Javoy-Agid; Yves Agid
Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.
Journal of neurochemistry 1991;56(2):446-51.
1991: I Ceballos; France Javoy-Agid; André Delacourte; A Defossez; M Lafon; Etienne C Hirsch; Annie Nicole; Pierre-Marie Sinet; Yves Agid
Neuronal localization of copper-zinc superoxide dismutase protein and mRNA within the human hippocampus from control and Alzheimer's disease brains.
Free radical research communications 1991;12-13 Pt 2():571-80.
1991: Jean-Philippe Brandel; Etienne C Hirsch; S Malessa; Charles Duyckaerts; P Cervera; Yves Agid
Differential vulnerability of cholinergic projections to the mediodorsal nucleus of the thalamus in senile dementia of Alzheimer type and progressive supranuclear palsy.
Neuroscience 1991;41(1):25-31.
1991: Charles Pierrot-Deseilligny; Sophie Rivaud; Bertrand Gaymard; Yves Agid
Cortical control of memory-guided saccades in man.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1991;83(3):607-17.
1991: Jorge L Juncos; Etienne C Hirsch; S Malessa; Charles Duyckaerts; Louis B Hersh; Yves Agid
Mesencephalic cholinergic nuclei in progressive supranuclear palsy.
Neurology 1991;41(1):25-30.
1991: C P Jedynak; Anne-Marie Bonnet; Yves Agid
Tremor and idiopathic dystonia.
Movement disorders : official journal of the Movement Disorder Society 1991;6(3):230-6.
1991: Bernard Pillon; Bruno Dubois; Yves Agid
Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy.
Annals of the New York Academy of Sciences 1991;640():224-7.
1990: C Chavoix; Yves Samson; Sabina Pappata; C Prenant; M Mazière; A Seck; Yves Agid
Positron emission tomography study of brain benzodiazepine receptors in Friedreich's ataxia.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1990;17(4):404-9.
1990: S Malessa; Etienne C Hirsch; P Cervera; Charles Duyckaerts; Yves Agid
Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes: a quantitative immunohistochemical study in Parkinson's disease, progressive supranuclear palsy, and striatonigral degeneration.
Neurology 1990;40(11):1739-43.
1990: V M Mann; J Mark Cooper; France Javoy-Agid; Yves Agid; Peter Jenner; Anthony H V Schapira
Mitochondrial function and parental sex effect in Huntington's disease.
Lancet 1990;336(8717):749.
1990: M J Vidailhet; Anne-Marie Bonnet; S Belal; Bruno Dubois; C Marle; Yves Agid
Ropinirole without levodopa in Parkinson's disease.
Lancet 1990;336(8710):316-7.
1990: Bruno Dubois; B Pilon; F Lhermitte; Yves Agid
Cholinergic deficiency and frontal dysfunction in Parkinson's disease.
Annals of neurology 1990;28(2):117-21.
1990: J Blin; Jean-Claude Baron; Bruno Dubois; Bernard Pillon; H Cambon; J Cambier; Yves Agid
Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations.
Archives of neurology 1990;47(7):747-52.
1990: David T Dexter; A Carayon; M Vidailhet; M Ruberg; F Agid; Yves Agid; Andrew J Lees; F R Wells; Peter Jenner; CD Marsden
Decreased ferritin levels in brain in Parkinson's disease.
Journal of neurochemistry 1990;55(1):16-20.
1990: Jesse Cedarbaum; K F Sheu; B J Harding; John P Blass; France Javoy-Agid; Yves Agid
Deficiency of glutamate dehydrogenase in postmortem brain samples from parkinsonian putamen.
Annals of neurology 1990;28(1):111-2.
1990: Etienne C Hirsch; Charles Duyckaerts; France Javoy-Agid; JEAN-JACQUES HAUW; Yves Agid
Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?
Annals of neurology 1990;27(6):676-82.
1990: André Hanauer; R Fujita; Paul Trouillas; C Tommasi-Davenas; Yves Agid; A Seck; Jean-Louis Mandel
Prenatal diagnosis of Friedreich ataxia.
Lancet 1990;335(8697):1102.
1990: I Ceballos; M Lafon; France Javoy-Agid; Etienne C Hirsch; A Nicole; P M Sinet; Yves Agid
Superoxide dismutase and Parkinson's disease.
Lancet 1990;335(8696):1035-6.
1990: S Dumas; France Javoy-Agid; Etienne C Hirsch; Yves Agid; J Mallet
Tyrosine hydroxylase gene expression in human ventral mesencephalon: detection of tyrosine hydroxylase messenger RNA in neurites.
Journal of neuroscience research 1990;25(4):569-75.
1990: P Cervera; Charles Duyckaerts; Merle Ruberg; Etienne C Hirsch; G Ransmayr; JEAN-JACQUES HAUW; Yves Agid
Tyrosine hydroxylase-like immunoreactivity in senile plaques is not related to the density of tyrosine hydroxylase-positive fibers in patients with Alzheimer's disease.
Neuroscience letters 1990;110(1-2):210-5.
1990: Rita Raisman-Vozari; Jean-Antoine Girault; Saliha Moussaoui; Claude Feuerstein; Peter Jenner; CD Marsden; Yves Agid
Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man.
Brain research 1990;507(1):45-50.
1990: Bruno Dubois; B Pillon; N Sternic; F Lhermitte; Yves Agid
Age-induced cognitive disturbances in Parkinson's disease.
Neurology 1990;40(1):38-41.
1990: Yves Agid
[From posture to initiation of movement].
Revue neurologique 1990;146(10):536-42.
1990: Merle Ruberg; W Mayo; Alexis Brice; Charles Duyckaerts; JEAN-JACQUES HAUW; H Simon; M LeMoal; Yves Agid
Choline acetyltransferase activity and [3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions.
Neuroscience 1990;35(2):327-33.
1990: Florence Thibaut; Etienne C Hirsch; R Raisman; France Javoy-Agid; Yves Agid
Microtopography of D1 dopaminergic binding sites in the human substantia nigra: an autoradiographic study.
Neuroscience 1990;37(2):387-98.
1990: France Javoy-Agid; Etienne C Hirsch; Sylvie Dumas; Charles Duyckaerts; Jacques Mallet; Yves Agid
Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study.
Neuroscience 1990;38(1):245-53.
1990: Yves Agid; Ann M Graybiel; Merle Ruberg; Etienne C Hirsch; J Blin; Bruno Dubois; France Javoy-Agid
The efficacy of levodopa treatment declines in the course of Parkinson's disease: do nondopaminergic lesions play a role?
Advances in neurology 1990;53():83-100.
1990: Ann M Graybiel; Etienne C Hirsch; Yves Agid
The nigrostriatal system in Parkinson's disease.
Advances in neurology 1990;53():17-29.
1989: Stéphane Lehéricy; Etienne C Hirsch; P Cervera; Louis B Hersh; JEAN-JACQUES HAUW; Merle Ruberg; Yves Agid
Selective loss of cholinergic neurons in the ventral striatum of patients with Alzheimer disease.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(21):8580-4.
1989: M Vidailhet; M Serdaru; Yves Agid
Singing in the brain: a new form of complex partial seizure?
Journal of neurology, neurosurgery, and psychiatry 1989;52(11):1306.
1989: J Blin; Jean-Claude Baron; H Cambon; Anne-Marie Bonnet; Bruno Dubois; Christian Loc'h; B Mazière; Yves Agid
Striatal dopamine D2 receptors in tardive dyskinesia: PET study.
Journal of neurology, neurosurgery, and psychiatry 1989;52(11):1248-52.
1989: I Ceballos; France Javoy-Agid; Etienne C Hirsch; S Dumas; Pierre Kamoun; Pierre-Marie Sinet; Yves Agid
Localization of copper-zinc superoxide dismutase mRNA in human hippocampus by in situ hybridization.
Neuroscience letters 1989;105(1-2):41-6.
1989: D Scherman; C Desnos; F Darchen; Pierre Pollak; France Javoy-Agid; Yves Agid
Striatal dopamine deficiency in Parkinson's disease: role of aging.
Annals of neurology 1989;26(4):551-7.
1989: Bernard Pillon; Bruno Dubois; Anne-Marie Bonnet; M Esteguy; J Guimaraes; J M Vigouret; F Lhermitte; Yves Agid
Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test.
Neurology 1989;39(6):762-8.
1989: David T Dexter; F R Wells; Andrew J Lees; F Agid; Yves Agid; Peter Jenner; CD Marsden
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.
Journal of neurochemistry 1989;52(6):1830-6.
1989: Jorge L Juncos; T M Engber; R Raisman; Z Susel; Florence Thibaut; A Ploska; Yves Agid; Thomas N Chase
Continuous and intermittent levodopa differentially affect basal ganglia function.
Annals of neurology 1989;25(5):473-8.
1989: Charles Pierrot-Deseilligny; E Turell; C Penet; D Lebrigand; Bernard Pillon; F Chain; Yves Agid
Increased wave P 300 latency in progressive supranuclear palsy.
Journal of neurology, neurosurgery, and psychiatry 1989;52(5):656-8.
1989: Jean-Antoine Girault; Rita Raisman-Vozari; Yves Agid; Paul Greengard
Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsy.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(7):2493-7.
1989: Charles Pierrot-Deseilligny; Sophie Rivaud; Bernard Pillon; E Fournier; Yves Agid
Lateral visually-guided saccades in progressive supranuclear palsy.
Brain : a journal of neurology 1989;112 ( Pt 2)():471-87.
1989: Yves Agid
[Parkinson's disease: some physiopathologic aspects and clinical practice].
La Revue du praticien 1989;39(8):641-6.
1989: David T Dexter; Chris Carter; F R Wells; France Javoy-Agid; Yves Agid; Andrew J Lees; Peter Jenner; CD Marsden
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease.
Journal of neurochemistry 1989;52(2):381-9.
1989: Bernard Pillon; Bruno Dubois; G Cusimano; Anne-Marie Bonnet; F Lhermitte; Yves Agid
Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?
Journal of neurology, neurosurgery, and psychiatry 1989;52(2):201-6.
1989: Etienne C Hirsch; Ann M Graybiel; Louis B Hersh; Charles Duyckaerts; Yves Agid
Striosomes and extrastriosomal matrix contain different amounts of immunoreactive choline acetyltransferase in the human striatum.
Neuroscience letters 1989;96(2):145-50.
1989: E Pourcher; Anne-Marie Bonnet; J Kefalos; Bruno Dubois; Yves Agid
Effects of etybenzatropine and diazepam on levodopa-induced diphasic dyskinesias in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1989;4(3):195-201.
1989: Jacques Vignon; I Chaudieu; H Allaoua; L Journod; France Javoy-Agid; Yves Agid; R Chicheportiche
Comparison of [3H] phencyclidine ([3H] PCP) and [3H] N-[1-(2-thienyl) cyclohexyl] piperidine ([3H] TCP) binding properties to rat and human brain membranes.
Life sciences 1989;45(26):2547-55.
1989: G Ransmayr; P Cervera; Etienne C Hirsch; Merle Ruberg; Louis B Hersh; Charles Duyckaerts; JEAN-JACQUES HAUW; C Delumeau; Yves Agid
Choline acetyltransferase-like immunoreactivity in the hippocampal formation of control subjects and patients with Alzheimer's disease.
Neuroscience 1989;32(3):701-14.
1989: Etienne C Hirsch; Ann M Graybiel; Yves Agid
Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease.
Acta neurologica Scandinavica. Supplementum 1989;126():19-22.
1989: J A Temlett; Niall Quinn; P G Jenner; CD Marsden; E Pourcher; Anne-Marie Bonnet; Yves Agid; R Markstein; X Lataste
Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1989;4(3):261-5.
1989: Yves Agid; P Cervera; Etienne C Hirsch; France Javoy-Agid; S Lehericy; R Raisman; Merle Ruberg
Biochemistry of Parkinson's disease 28 years later: a critical review.
Movement disorders : official journal of the Movement Disorder Society 1989;4 Suppl 1():S126-44.
1989: J Epelbaum; F Agid; Yves Agid; A Beaudet; P Bertrand; A Enjalbert; V Heidet; C Kordon; S Krantic; J F Léonard
Somatostatin receptors in brain and pituitary.
Hormone research 1989;31(1-2):45-50.
1989: R Fujita; Yves Agid; Paul Trouillas; A Seck; C Tommasi-Davenas; A J Driesel; K Olek; K H Grzeschik; Y Nakamura; Jean-Louis Mandel; André Hanauer
Confirmation of linkage of Friedreich ataxia to chromosome 9 and identification of a new closely linked marker.
Genomics 1989;4(1):110-1.
1989: France Javoy-Agid; B Scatton; Merle Ruberg; R L'Heureux; P Cervera; R Raisman; J M Maloteaux; H Beck; Yves Agid
Distribution of monoaminergic, cholinergic, and GABAergic markers in the human cerebral cortex.
Neuroscience 1989;29(2):251-9.
1988: H Taquet; France Javoy-Agid; Annie Mauborgne; Jean-Jacques Benoliel; Yves Agid; J C Legrand; G Tramu; François Cesselin; Michel Hamon
Biochemical mapping of cholecystokinin-, substance P-, [Met]enkephalin-, [Leu]enkephalin- and dynorphin A (1-8)-like immunoreactivities in the human cerebral cortex.
Neuroscience 1988;27(3):871-83.
1988: Jean-Marie Maloteaux; M A Vanisberg; C Laterre; France Javoy-Agid; Yves Agid; P M Laduron
[3H]GBR 12935 binding to dopamine uptake sites: subcellular localization and reduction in Parkinson's disease and progressive supranuclear palsy.
European journal of pharmacology 1988;156(3):331-40.
1988: Bruno Dubois; B Pillon; F Legault; Yves Agid; F Lhermitte
Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson's disease.
Archives of neurology 1988;45(11):1194-9.
1988: J Epelbaum; France Javoy-Agid; A Enjalbert; S Krantic; C Kordon; Yves Agid
Somatostatin concentrations and binding sites in human frontal cortex are differentially affected in Parkinson's disease associated dementia and in progressive supranuclear palsy.
Journal of the neurological sciences 1988;87(2-3):167-74.
1988: H Taquet; M Nomoto; S Rose; Peter Jenner; France Javoy-Agid; Annie Mauborgne; Jean-Jacques Benoliel; CD Marsden; J C Legrand; Yves Agid
Levels of Met-enkephalin, Leu-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatment.
Neuropeptides 1988;12(3):105-10.
1988: J Blin; Anne-Marie Bonnet; Yves Agid
Does levodopa aggravate Parkinson's disease?
Neurology 1988;38(9):1410-6.
1988: Laurent Pierot; C Desnos; J Blin; R Raisman; D Scherman; France Javoy-Agid; Merle Ruberg; Yves Agid
D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy.
Journal of the neurological sciences 1988;86(2-3):291-306.
1988: Etienne C Hirsch; Ann M Graybiel; Yves Agid
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.
Nature 1988;334(6180):345-8.
1988: Sylvie Jégou; France Javoy-Agid; C Delbende; D Tranchand-Bunel; D H Coy; Yves Agid; Hubert Vaudry
Regional distribution of vasoactive intestinal peptide in brains from normal and parkinsonian subjects.
Peptides 1988;9(4):787-93.
1988: Yves Agid; B Pertuiset; Bruno Dubois
Motoneuron disease as manifestation of lupin seed toxicity.
Lancet 1988;1(8598):1347.
1988: Jean-Marie Maloteaux; M A Luabeya; M A Vanisberg; E C Laterre; P M Laduron; France Javoy-Agid; Yves Agid
Benzodiazepine receptors in normal human brain, in Parkinson's disease and in progressive supranuclear palsy.
Brain research 1988;446(2):321-32.
1988: D Scherman; R Raisman; A Ploska; Yves Agid
[3H]dihydrotetrabenazine, a new in vitro monoaminergic probe for human brain.
Journal of neurochemistry 1988;50(4):1131-6.
1988: Etienne C Hirsch; Merle Ruberg; M M Portier; M Dardenne; Yves Agid
Characterization of two antigens in parkinsonian Lewy bodies.
Brain research 1988;441(1-2):139-44.
1988: M Ruberg; A Villageois; Anne-Marie Bonnet; François Rieger; Yves Agid; Stanley Fahn
Acetylcholinesterase and butyrylcholinesterase in cerebrospinal fluid from patients with dystonia.
Advances in neurology 1988;50():211-3.
1988: Jean-Marie Maloteaux; E C Laterre; P M Laduron; France Javoy-Agid; Yves Agid
Decrease of serotonin-S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy.
Movement disorders : official journal of the Movement Disorder Society 1988;3(3):255-62.
1987: David T Dexter; F R Wells; F Agid; Yves Agid; Andrew J Lees; Peter Jenner; CD Marsden
Increased nigral iron content in postmortem parkinsonian brain.
Lancet 1987;2(8569):1219-20.
1987: J Epelbaum; France Javoy-Agid; Etienne C Hirsch; JEAN-JACQUES HAUW; C Kordon; S Krantic; Yves Agid
Brain somatostatin concentrations do not decrease in progressive supranuclear palsy.
Journal of neurology, neurosurgery, and psychiatry 1987;50(11):1526-8.
1987: R Cash; R Raisman; A Ploska; Yves Agid
Dopamine D-1 receptor and cyclic AMP-dependent phosphorylation in Parkinson's disease.
Journal of neurochemistry 1987;49(4):1075-83.
1987: Anne-Marie Bonnet; Y Loria; M H Saint-Hilaire; F Lhermitte; Yves Agid
Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions?
Neurology 1987;37(9):1539-42.
1987: Bruno Dubois; F Danzé; Bernard Pillon; G Cusimano; F Lhermitte; Yves Agid
Cholinergic-dependent cognitive deficits in Parkinson's disease.
Annals of neurology 1987;22(1):26-30.
1987: P Delay-Goyet; J M Zajac; France Javoy-Agid; Yves Agid; Bernard P Roques
Regional distribution of mu, delta and kappa opioid receptors in human brains from controls and parkinsonian subjects.
Brain research 1987;414(1):8-14.
1987: H Taquet; France Javoy-Agid; Annie Mauborgne; Jean-Jacques Benoliel; Yves Agid; J C Legrand; M Hamon; François Cesselin
Brain neuropeptides in progressive supranuclear palsy.
Brain research 1987;411(1):178-82.
1987: M Ruberg; A Villageois; Anne-Marie Bonnet; B Pillon; François Rieger; Yves Agid
Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems.
Journal of neurology, neurosurgery, and psychiatry 1987;50(5):538-43.
1987: Yves Agid; J Blin
Nerve cell death in degenerative diseases of the central nervous system: clinical aspects.
Ciba Foundation symposium 1987;126():3-29.
1987: William Koller; R O'Hara; William J Weiner; Anthony E Lang; John G Nutt; Yves Agid; Anne-Marie Bonnet; Joseph Jankovic
Relationship of aging to Parkinson's disease.
Advances in neurology 1987;45():317-21.
1987: Anne-Marie Bonnet; G Tell; P J Schechter; J Grove; M H Saint-Hilaire; Y De Smet; Yves Agid
Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea.
Movement disorders : official journal of the Movement Disorder Society 1987;2(2):117-23.
1987: R Cash; R Raisman; P Cervera; France Javoy-Agid; Yves Agid
Pitfalls in membrane binding sites studies in post-mortem human brain.
Journal of receptor research 1987;7(1-4):527-54.
1987: Yves Agid; France Javoy-Agid; M Ruberg; B Pillon; Bruno Dubois; Charles Duyckaerts; JEAN-JACQUES HAUW; J C Baron; B Scatton
Progressive supranuclear palsy: anatomoclinical and biochemical considerations.
Advances in neurology 1987;45():191-206.
1987: Ann M Graybiel; Etienne C Hirsch; Yves Agid
Differences in tyrosine hydroxylase-like immunoreactivity characterize the mesostriatal innervation of striosomes and extrastriosomal matrix at maturity.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(1):303-7.
1986: A Sarrieau; M Dussaillant; F Agid; D Philibert; Yves Agid; W Rostene
Autoradiographic localization of glucocorticosteroid and progesterone binding sites in the human post-mortem brain.
Journal of steroid biochemistry 1986;25(5B):717-21.
1986: Anne-Marie Bonnet; M Esteguy; G Tell; P J Schechter; J Hardenberg; Yves Agid
A controlled study of oral vigabatrin (gamma-vinyl GABA) in patients with cerebellar ataxia.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1986;13(4):331-3.
1986: Peter Jenner; H Taquet; Annie Mauborgne; J T Benoliel; François Cesselin; S Rose; France Javoy-Agid; Yves Agid; CD Marsden
Lack of change in basal ganglia neuropeptide content following subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of the common marmoset.
Journal of neurochemistry 1986;47(5):1548-51.
1986: David T Dexter; Chris Carter; F Agid; Yves Agid; Andrew J Lees; Peter Jenner; CD Marsden
Lipid peroxidation as cause of nigral cell death in Parkinson's disease.
Lancet 1986;2(8507):639-40.
1986: B Pillon; Bruno Dubois; F Lhermitte; Yves Agid
Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease.
Neurology 1986;36(9):1179-85.
1986: Bruno Dubois; B Pillon; H De Saxce; F Lhermitte; Yves Agid
Disappearance of parkinsonian signs after spontaneous vascular 'thalamotomy'.
Archives of neurology 1986;43(8):815-7.
1986: R Cash; R Raisman; L Lanfumey; A Ploska; Yves Agid
Cellular localization of adrenergic receptors in rat and human brain.
Brain research 1986;370(1):127-35.
1986: Jean-Claude Baron; B Mazière; Christian Loc'h; H Cambon; P Sgouropoulos; Anne-Marie Bonnet; Yves Agid
Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1986;6(2):131-6.
1986: R Raisman; R Cash; Yves Agid
Parkinson's disease: decreased density of 3H-imipramine and 3H-paroxetine binding sites in putamen.
Neurology 1986;36(4):556-60.
1986: Bruno Dubois; Yves Agid
[Dopaminergic agonists in Parkinson disease].
La Revue du praticien 1986;36(5):207-14.
1986: M Ruberg; François Rieger; A Villageois; Anne-Marie Bonnet; Yves Agid
Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease.
Brain research 1986;362(1):83-91.
1986: Yves Agid; M Ruberg; Bruno Dubois; Bernard Pillon; G Cusimano; R Raisman; R Cash; F Lhermitte; France Javoy-Agid
Parkinson's disease and dementia.
Clinical neuropharmacology 1986;9 Suppl 2():S22-36.
1986: Yves Agid; H Taquet; F Cesselin; J Epelbaum; France Javoy-Agid
Neuropeptides and Parkinson's disease.
Progress in brain research 1986;66():107-16.
1985: A Sarrieau; France Javoy-Agid; Patrick Kitabgi; M Dussaillant; M Vial; J P Vincent; Yves Agid; William Rostène
Characterization and autoradiographic distribution of neurotensin binding sites in the human brain.
Brain research 1985;348(2):375-80.
1985: R Cash; R Raisman; A Ploska; Yves Agid
High and low affinity [3H]imipramine binding sites in control and parkinsonian brains.
European journal of pharmacology 1985;117(1):71-80.
1985: Etienne C Hirsch; M Ruberg; M Dardenne; M M Portier; France Javoy-Agid; J F Bach; Yves Agid
Monoclonal antibodies raised against Lewy bodies in brains from subjects with Parkinson's disease.
Brain research 1985;345(2):374-8.
1985: R D'Antona; J C Baron; Y Samson; M Serdaru; F Viader; Yves Agid; J Cambier
Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy.
Brain : a journal of neurology 1985;108 ( Pt 3)():785-99.
1985: H Taquet; France Javoy-Agid; P Giraud; J C Legrand; Yves Agid; François Cesselin
Dynorphin levels in parkinsonian patients: Leu5-enkephalin production from either proenkephalin A or prodynorphin in human brain.
Brain research 1985;341(2):390-2.
1985: R Cash; F Lasbennes; R Sercombe; Jacques Seylaz; Yves Agid
Adrenergic receptors on cerebral microvessels in control and parkinsonian subjects.
Life sciences 1985;37(6):531-6.
1985: Sylvie Jegou; France Javoy-Agid; C Delbende; M Ruberg; H Vaudry; Yves Agid
Cortical vasoactive intestinal peptide in relation to dementia in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1985;48(8):842-3.
1985: R Raisman; R Cash; M Ruberg; France Javoy-Agid; Yves Agid
Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects.
European journal of pharmacology 1985;113(3):467-8.
1985: Bruno Dubois; W Mayo; Yves Agid; M Le Moal; H Simon
Profound disturbances of spontaneous and learned behaviors following lesions of the nucleus basalis magnocellularis in the rat.
Brain research 1985;338(2):249-58.
1985: J M Allen; A J Cross; T J Crow; France Javoy-Agid; Yves Agid; S R Bloom
Dissociation of neuropeptide Y and somatostatin in Parkinson's disease.
Brain research 1985;337(1):197-200.
1985: J C Monfort; France Javoy-Agid; JEAN-JACQUES HAUW; Bruno Dubois; Yves Agid
Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index.
Brain : a journal of neurology 1985;108 ( Pt 2)():301-13.
1985: Jean-Claude Baron; Bernard Maziere; Christian Loc'h; P Sgouropoulos; Anne-Marie Bonnet; Yves Agid
Progressive supranuclear palsy: loss of striatal dopamine receptors demonstrated in vivo by positron tomography.
Lancet 1985;1(8438):1163-4.
1985: Garth Bissette; Charles Nemeroff; M W Decker; J Kizer; Yves Agid; France Javoy-Agid
Alterations in regional brain concentrations of neurotensin and bombesin in Parkinson's disease.
Annals of neurology 1985;17(4):324-8.
1985: L Pique; S Jegou; Xavier Bertagna; France Javoy-Agid; D Seurin; M F Proeschel; F Girard; Yves Agid; H Vaudry; Jean Pierre Luton
Pro-opiomelanocortin peptides in the human hypothalamus: comparative study between normal subjects and Parkinson patients.
Neuroscience letters 1985;54(2-3):141-6.
1985: R Cash; R Raisman; M Ruberg; Yves Agid
Adrenergic receptors in frontal cortex in human brain.
European journal of pharmacology 1985;108(3):225-32.
1985: M Esteguy; Anne-Marie Bonnet; J Kefalos; F Lhermitte; Yves Agid
[The L-dopa test in Parkinson's disease].
Revue neurologique 1985;141(5):413-5.
1985: Bruno Dubois; JEAN-JACQUES HAUW; M Ruberg; M Serdaru; France Javoy-Agid; Yves Agid
[Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].
Revue neurologique 1985;141(3):184-93.
1985: Jean-Claude Baron; D Comar; E Zarifian; Yves Agid; C Crouzel; H Loo; P Deniker; C Kellershohn
Dopaminergic receptor sites in human brain: positron emission tomography.
Neurology 1985;35(1):16-24.
1985: Yves Agid; Anne-Marie Bonnet; M Ruberg; France Javoy-Agid
Pathophysiology of L-dopa-induced abnormal involuntary movements.
Psychopharmacology. Supplementum 1985;2():145-59.
1985: J C Baron; Y Samson; D Comar; C Crouzel; P Deniker; Yves Agid
[In vivo study of central serotoninergic receptors in man using positron tomography].
Revue neurologique 1985;141(8-9):537-45.
1985: J Epelbaum; Yves Agid; A Enjalbert; M Hamon; France Javoy-Agid; C Kordon; Y Lamour; E Moyse
Somatostatin alterations and brain diseases.
Advances in experimental medicine and biology 1985;188():261-74.
1984: R Cash; M Ruberg; R Raisman; Yves Agid
Adrenergic receptors in Parkinson's disease.
Brain research 1984;322(2):269-75.
1984: C Llorens-Cortes; France Javoy-Agid; Yves Agid; H Taquet; J C Schwartz
Enkephalinergic markers in substantia nigra and caudate nucleus from Parkinsonian subjects.
Journal of neurochemistry 1984;43(3):874-7.
1984: Anne-Marie Bonnet; M Esteguy; J Guimaraes; F Lhermitte; Yves Agid
Low-dose CU 32-085 (mesulergine) in previously untreated Parkinson's disease.
Neurology 1984;34(8):1127-8.
1984: D Rougemont; Jean-Claude Baron; P Collard; P Bustany; D Comar; Yves Agid
Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1984;47(8):824-30.
1984: J Y Mear; G Barroche; Y de Smet; M Weber; F Lhermitte; Yves Agid
Pergolide in the treatment of Parkinson's disease.
Neurology 1984;34(7):983-6.
1984: W Mayo; Bruno Dubois; A Ploska; France Javoy-Agid; Yves Agid; M Le Moal; H Simon
Cortical cholinergic projections from the basal forebrain of the rat, with special reference to the prefrontal cortex innervation.
Neuroscience letters 1984;47(2):149-54.
1984: France Javoy-Agid; M Ruberg; L Pique; X Bertagna; H Taquet; J M Studler; F Cesselin; J Epelbaum; Yves Agid
Biochemistry of the hypothalamus in Parkinson's disease.
Neurology 1984;34(5):672-5.
1984: J L Sadoul; P Kitabgi; W Rostène; France Javoy-Agid; Yves Agid; J P Vincent
Characterization and visualization of neurotensin binding to receptor sites in human brain.
Biochemical and biophysical research communications 1984;120(1):206-13.
1984: B Bokobza; M Ruberg; B Scatton; France Javoy-Agid; Yves Agid
[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy.
European journal of pharmacology 1984;99(2-3):167-75.
1984: M Ruberg; B Bokobza; France Javoy-Agid; J C Montfort; Yves Agid
[3H]spiperone binding in the nigrostriatal system in human brain.
European journal of pharmacology 1984;99(2-3):159-65.
1984: Yves Agid; A Ploska; J C Monfort; France Javoy-Agid
Striatal glutamate decarboxylase values, indicative of hospital where patient died.
Lancet 1984;1(8371):280.
1984: M Serdaru; L Lacomblez; F Danzé; Yves Agid
[Meningo-myelitis with a favorable course after measles vaccination].
Revue neurologique 1984;140(3):226-7.
1984: F Lhermitte; Yves Agid; M Serdaru; J Guimaraes
[Parkinson syndrome, frontal tumor and L-dopa].
Revue neurologique 1984;140(2):138-9.
1984: Yves Agid; M Ruberg; Bruno Dubois; France Javoy-Agid
Biochemical substrates of mental disturbances in Parkinson's disease.
Advances in neurology 1984;40():211-8.
1984: France Javoy-Agid; M Ruberg; H Taquet; B Bokobza; Yves Agid; patricia Gaspar; B Berger; J N'Guyen-Legros; C Alvarez; F Gray
Biochemical neuropathology of Parkinson's disease.
Advances in neurology 1984;40():189-98.
1983: Bruno Dubois; M Ruberg; France Javoy-Agid; A Ploska; Yves Agid
A subcortico-cortical cholinergic system is affected in Parkinson's disease.
Brain research 1983;288(1-2):213-8.
1983: H Taquet; France Javoy-Agid; M Hamon; J C Legrand; Yves Agid; François Cesselin
Parkinson's disease affects differently Met5- and Leu5-enkephalin in the human brain.
Brain research 1983;280(2):379-82.
1983: J Epelbaum; M Ruberg; E Moyse; France Javoy-Agid; Bruno Dubois; Yves Agid
Somatostatin and dementia in Parkinson's disease.
Brain research 1983;278(1-2):376-9.
1983: C Pimoule; H Schoemaker; France Javoy-Agid; B Scatton; Yves Agid; S Z Langer
Decrease in [3H]cocaine binding to the dopamine transporter in Parkinson's disease.
European journal of pharmacology 1983;95(1-2):145-6.
1983: M Sette; M Ruberg; R Raisman; B Scatton; B Zivkovic; Yves Agid; S Z Langer
[3H]imipramine binding in subcellular fractions of rat cerebral cortex after chemical lesion of serotonergic neurons.
European journal of pharmacology 1983;95(1-2):41-51.
1983: B Scatton; France Javoy-Agid; L Rouquier; Bruno Dubois; Yves Agid
Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.
Brain research 1983;275(2):321-8.
1983: France Javoy-Agid; D Grouselle; A Tixier-Vidal; Yves Agid
Thyrotropin releasing hormone content is unchanged in brains of patients with Parkinson disease.
Neuropeptides 1983;3(5):405-10.
1983: Annie Mauborgne; France Javoy-Agid; J C Legrand; Yves Agid; F Cesselin
Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains.
Brain research 1983;268(1):167-70.
1983: Roland Jouvent; P Abensour; Anne-Marie Bonnet; D Widlocher; Yves Agid; F Lhermitte
Antiparkinsonian and antidepressant effects of high doses of bromocriptine. An independent comparison.
Journal of affective disorders 1983;5(2):141-5.
1983: T L Perry; France Javoy-Agid; Yves Agid; H C Fibiger
Striatal GABAergic neuronal activity is not reduced in Parkinson's disease.
Journal of neurochemistry 1983;40(4):1120-3.
1983: patricia Gaspar; B Berger; M Gay; M Hamon; F Cesselin; A Vigny; France Javoy-Agid; Yves Agid
Tyrosine hydroxylase and methionine-enkephalin in the human mesencephalon. Immunocytochemical localization and relationships.
Journal of the neurological sciences 1983;58(2):247-67.
1983: K G Lloyd; G De Montis; France Javoy-Agid; K Beaumont; A Lowenthal; J Constantinidis; Yves Agid
Glycine receptors in the human brain: characterization of 3H-strychnine binding and status in pathological conditions.
Advances in biochemical psychopharmacology 1983;36():233-8.
1983: Yves Agid; Alain Destée; A Lallemand
Effect of a methionine-enkephalin analog in Huntington's disease.
Advances in neurology 1983;37():299-304.
1983: Yves Agid
[Neurotransmission].
Revue neurologique 1983;139(10):539-45.
1983: M Garbarg; France Javoy-Agid; J C Schwartz; Yves Agid
Brain histidine decarboxylase activity in Parkinson's disease.
Lancet 1983;1(8314-5):74-5.
1982: Y de Smet; M Ruberg; M Serdaru; Bruno Dubois; F Lhermitte; Yves Agid
Confusion, dementia and anticholinergics in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1982;45(12):1161-4.
1982: J Grove; P J Schechter; N F Hanke; Y de Smet; Yves Agid; G Tell; J Koch-Weser
Concentration gradients of free and total gamma-aminobutyric acid and homocarnosine in human CSF: comparison of suboccipital and lumbar sampling.
Journal of neurochemistry 1982;39(6):1618-22.
1982: A Ploska; H Taquet; France Javoy-Agid; patricia Gaspar; François Cesselin; B Berger; M Hamon; J C Legrand; Yves Agid
Dopamine and methionine-enkephalin in human brain.
Neuroscience letters 1982;33(2):191-6.
1982: C Llorens; B Malfroy; J C Schwartz; G Gacel; Bernard P Roques; J Roy; J L Morgat; France Javoy-Agid; Yves Agid
Enkephalin dipeptidyl carboxypeptidase (enkephalinase) activity: selective radioassay, properties, and regional distribution in human brain.
Journal of neurochemistry 1982;39(4):1081-9.
1982: B Scatton; L Rouquier; France Javoy-Agid; Yves Agid
Dopamine deficiency in the cerebral cortex in Parkinson disease.
Neurology 1982;32(9):1039-40.
1982: J M Studler; France Javoy-Agid; F Cesselin; J C Legrand; Yves Agid
CCK-8-Immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients.
Brain research 1982;243(1):176-9.
1982: Y De Smet; J Y Mear; G Tell; P H Schechter; F Lhermitte; Yves Agid
Effect of gamma-vinyl GABA in Friedreich's ataxia.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1982;9(2):171-3.
1982: H Taquet; France Javoy-Agid; François Cesselin; M Hamon; J C Legrand; Yves Agid
Microtopography of methionine-enkephalin, dopamine and noradrenaline in the ventral mesencephalon of human control and Parkinsonian brains.
Brain research 1982;235(2):303-14.
1982: G de Montis; K Beaumont; France Javoy-Agid; Yves Agid; J Constandinidis; A Lowenthal; K G Lloyd
Glycine receptors in the human substantia nigra as defined by [3H]strychnine binding.
Journal of neurochemistry 1982;38(3):718-24.
1982: M Ruberg; A Ploska; France Javoy-Agid; Yves Agid
Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.
Brain research 1982;232(1):129-39.
1982: J C Schwartz; S de la Baume; C Llorens; B Malfroy; E Soroca; Marie-Claude Fournié-Zaluski; Bernard P Roques; J L Morgat; J Roy; France Javoy-Agid; Yves Agid
Enkephalin dipeptidyl carboxypeptidase ("enkephalinase"): assay, properties, and distribution in human brain and exploration of the active site.
Advances in biochemical psychopharmacology 1982;33():225-34.
1982: Alain Destée; H Petit; P Warot; F Lhermitte; Yves Agid
[Effect of a synthetic analog of enkephalin on the choreic syndrome].
Revue neurologique 1982;138(11):845-9.
1982: France Javoy-Agid; M Ruberg; H Taquet; J M Studler; M Garbarg; C Llorens; J C Schwartz; D Grouselle; K G Lloyd; R Raisman; Yves Agid
Biochemical neuroanatomy of the human substantia nigra (pars compacta) in normal and Parkinsonian subjects.
Advances in neurology 1982;35():151-63.
1981: France Javoy-Agid; A Ploska; Yves Agid
Microtopography of tyrosine hydroxylase, glutamic acid decarboxylase, and choline acetyltransferase in the substantia nigra and ventral tegmental area of control and Parkinsonian brains.
Journal of neurochemistry 1981;37(5):1218-27.
1981: S Z Langer; France Javoy-Agid; R Raisman; M Briley; Yves Agid
Distribution of specific high-affinity binding sites for [3H]imipramine in human brain.
Journal of neurochemistry 1981;37(2):267-71.
1981: H Taquet; France Javoy-Agid; F Cesselin; Yves Agid
Methionine-enkephalin deficiency in brains of patients with Parkinson's disease.
Lancet 1981;1(8234):1367-8.
1981: France Javoy-Agid; H Taquet; A Ploska; C Cherif-Zahar; M Ruberg; Yves Agid
Distribution of catecholamines in the ventral mesencephalon of human brain, with special reference to Parkinson's disease.
Journal of neurochemistry 1981;36(6):2101-5.
1981: Niall Quinn; A Illas; F Lhermitte; Yves Agid
Bromocriptine and domperidone in the treatment of Parkinson disease.
Neurology 1981;31(6):662-7.
1981: Niall Quinn; A Illas; F Lhermitte; Yves Agid
Bromocriptine in Parkinson's disease: a study of cardiovascular effects.
Journal of neurology, neurosurgery, and psychiatry 1981;44(5):426-9.
1981: G Tell; P Böhlen; P J Schechter; J Koch-Weser; Yves Agid; Anne-Marie Bonnet; G Coquillat; G Chazot; C Fischer
Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration.
Neurology 1981;31(2):207-11.
1981: Yves Agid; Niall Quinn; F Lhermitte
[Long-term results of treatment of Parkinson's disease with bromocriptine and domperidone (author's transl)].
Revue neurologique 1981;137(1):49-51.
1980: France Javoy-Agid; Yves Agid
Is the mesocortical dopaminergic system involved in Parkinson disease?
Neurology 1980;30(12):1326-30.
1980: G Barbin; J M Palacios; M Garbarg; J C Schwartz; patricia Gaspar; France Javoy-Agid; Yves Agid
L-Histidine decarboxylase in the human brain: properties and localization.
Journal of neurochemistry 1980;35(2):400-6.
1980: P Böhlen; G Tell; P J Schechter; J Koch-Weser; Yves Agid; G Coquillat; G Chazot; C Fischer
Cerebrospinal fluid homocarnosine in Huntington's disease.
Life sciences 1980;26(13):1009-12.
1980: patricia Gaspar; France Javoy-Agid; A Ploska; Yves Agid
Regional distribution of neurotransmitter synthesizing enzymes in the basal ganglia of human brain.
Journal of neurochemistry 1980;34(2):278-83.
1979: A Whiteley; J L Signoret; Yves Agid; F Lhermitte
[Influence of choline on amnesia in Alzheimer's disease (author's transl)].
Revue neurologique 1979;135(8-9):565-72.
1979: G Kato; Yves Agid
[Acetylcholine receptors (author's transl)].
La Nouvelle presse médicale 1979;8(29):2407-11.
1979: M E Schwab; U Otten; Yves Agid; H Thoenen
Nerve growth factor (NGF) in the rat CNS: absence of specific retrograde axonal transport and tyrosine hydroxylase induction in locus coeruleus and substantia nigra.
Brain research 1979;168(3):473-83.
1979: Yves Agid; G Barroche; Anne-Marie Bonnet; France Javoy-Agid; G Kato; F Lhermitte; Pierre Pollak; J L Signoret
Dopamine receptor stimulating agonists in the treatment of Parkinson's disease.
Biomedicine / [publiée pour l'A.A.I.C.I.G.] 1979;30(2):67-71.
1979: Yves Agid; Pierre Pollak; Anne-Marie Bonnet; J L Signoret; F Lhermitte
Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease.
Lancet 1979;1(8116):570-2.
1979: J Puymirat; France Javoy-Agid; patricia Gaspar; A Ploska; A Prochiantz; Yves Agid
Post mortem stability and storage in the cold of brain enzymes.
Journal of neurochemistry 1979;32(2):449-54.
1978: F Lhermitte; J L Signoret; Yves Agid; F Laffont; R Jouvent
[Treatment of a hallucinatory state with diurnal hypersomnia using oxolinic acid].
La Nouvelle presse médicale 1978;7(43):3936.
1978: M E Schwab; France Javoy-Agid; Yves Agid
Labeled wheat germ agglutinin (WGA) as a new, highly sensitive retrograde tracer in the rat brain hippocampal system.
Brain research 1978;152(1):145-50.
1978: F Lhermitte; Yves Agid; J L Signoret
Onset and end-of-dose levodopa-induced dyskinesias. Possible treatment by increasing the daily doses of levodopa.
Archives of neurology 1978;35(5):261-3.
1978: L Peyrin; J M Cottet-Emard; France Javoy-Agid; Yves Agid; A Herbet; J Glowinski
Long-term effects of unilateral 6-hydroxydopamine destruction of the dopaminergic nigrostriatal pathway on the urinary excretion of catecholamines (dopamine, norepinephrine, epinephrine) and their metabolites in the rat.
Brain research 1978;143(3):567-72.
1978: M Arluison; Yves Agid; France Javoy-Agid
Dopaminergic nerve endings in the neostriatum of the rat--2. Radioautographic study following local micro-injections of tritiated dopamine.
Neuroscience 1978;3(8):675-83.
1978: M Arluison; Yves Agid; France Javoy-Agid
Dopaminergic nerve endings in the neostriatum of the rat--1. Identification by intracerebral injections of 5-hydroxydopamine.
Neuroscience 1978;3(8):657-73.
1977: F Lhermitte; Yves Agid; C Feuerstein; F Serre; J L Signoret; J M Studler; Anne-Marie Bonnet
[Abnormal movements caused by L-DOPA in patients with Parkinson's disease: correlation with the plasma concentrations of DOPA and O-methyl-DOPA].
Revue neurologique 1977;133(8-9):445-54.
1977: M Schwab; Yves Agid; J Glowinski; H Thoenen
Retrograde axonal transport of 125I-tetanus toxin as a tool for tracing fiber connections in the central nervous system; connections of the rostral part of the rat neostriatum.
Brain research 1977;126(2):211-24.
1977: F Lhermitte; Yves Agid; J L Signoret; J M Studler
["Beginning and end of dose" dyskinesias caused by L-DOPA].
Revue neurologique 1977;133(5):297-308.
1977: France Javoy-Agid; C Euvrard; A Herbet; J Bockaert; A Enjalbert; Yves Agid; J Glowinski
Lack of involvement of dopaminergic and GABA neurones in the inhbitory effect of harmaline on the activity of striatal cholinergic neurones in the rat.
Naunyn-Schmiedeberg's archives of pharmacology 1977;297(3):233-9.
1976: Yves Agid
[Neurochemical methods].
Revue d'électroencéphalographie et de neurophysiologie clinique 1976;6(4):444-6.
1976: France Javoy-Agid; C Sotelo; A Herbet; Yves Agid
Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine system.
Brain research 1976;102(2):201-15.
1975: Yves Agid
[Neuropharmacologic approach in Huntington's chorea].
Revue neurologique 1975;131(12):847-65.
1975: France Javoy-Agid; Yves Agid; J Glowinski
Oxotremorine- and atropine-induced changes of dopamine metabolism in the rat striatum.
The Journal of pharmacy and pharmacology 1975;27(9):677-81.
1975: Yves Agid; P Guyenet; J Glowinski; J C Beaujouan; France Javoy-Agid
Inhibitory influence of the nigrostriatal dopamine system on the striatal cholinergic neurons in the rat.
Brain research 1975;86(3):488-92.
1975: P G Guyenet; France Javoy-Agid; Yves Agid; J C Beaujouan; J Glowinski
Dopamine receptors and cholinergic neurons in the rat neostriatum.
Advances in neurology 1975;9():43-51.
1974: Yves Agid; France Javoy-Agid; J Glowimski
Chemical or electrolytic lesion of the substantia nigra: early effects on neostriatal dopamine metabolism.
Brain research 1974;74(1):41-9.
1974: P Guyenet; Yves Agid; France Javoy-Agid; J C Beaujouan; J Glowinski
[Selective action of neuroleptics on the cholinergic neurons of the neostriatum in the rat: antagonism to apomorphine].
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1974;278(21):2679-82.
1974: France Javoy-Agid; Yves Agid; D Bouvet; J Glowinski
Changes in neostriatal DA metabolism after carbachol or atropine microinjections into the substantia nigra.
Brain research 1974;68(2):253-60.
1974: France Javoy-Agid; Yves Agid; D Bouvet; J Glowinski
In vivo estimation of tyrosine hydroxylation in the dopaminergic terminals of the rat neostriatum.
The Journal of pharmacy and pharmacology 1974;26(3):179-85.
1973: Yves Agid; France Javoy-Agid; J Glowinski
Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat.
Nature: New biology 1973;245(144):150-1.
1973: Yves Agid; France Javoy-Agid; J Glowinski; D Bouvet; C Sotelo
Injection of 6-hydroxydopamine into the substantia nigra of the rat. II. Diffusion and specificity.
Brain research 1973;58(2):291-301.
1973: C Sotelo; France Javoy-Agid; Yves Agid; J Glowinski
Injection of 6-hydroxydopamine in the substantia nigra of the rat. I. Morphological study.
Brain research 1973;58(2):269-90.
1973: C Gauchy; Yves Agid; J Glowinski; A Cheramy
Acute effects of morphine on dopamine synthesis and release and tyrosine metabolism in the rat striatum.
European journal of pharmacology 1973;22(3):311-9.
1973: Yves Agid; France Javoy-Agid; Moussa B H Youdim
Monoamine oxidase and aldehyde dehydrogenase activity in the striatum of rats after 6-hydroxydopamine lesion of the nigrostriatal pathway.
British journal of pharmacology 1973;48(1):175-8.
1973: France Javoy-Agid; Moussa B H Youdim; Yves Agid; J Glowinski
Early effects of monoamine oxidase inhibitors on dopamine metabolism and monoamine oxidase activity in the neostriatum of the rat.
Journal of neural transmission 1973;34(4):279-89.
1972: France Javoy-Agid; Yves Agid; D Bouvet; J Glowinski
Feedback control of dopamine synthesis in dopaminergic terminals of the rat striatum.
The Journal of pharmacology and experimental therapeutics 1972;182(3):454-63.